,drug_name,section_name,gpt_output
0,KYPROLIS,adverse reactions,"Cardiac Toxicities, death, Acute Renal Failure, death, Tumor Lysis Syndrome, death, Pulmonary Toxicity, Pulmonary Hypertension, Dyspnea, Hypertension, Venous Thrombosis, Infusion Reactions, Thrombocytopenia, Hepatic Toxicity and Hepatic Failure, Thrombotic Thrombocytopenic Purpura/Hemolytic Uremic Syndrome, Posterior Reversible Encephalopathy Syndrome, Anemia, Fatigue, Nausea, Pyrexia, Decreased Platelets, Diarrhea, Decreased Lymphocyte, Headache, Cough, Edema Peripheral, Neutropenia, Decreased Total White Blood Cell Count, Muscle Spasms, Upper Respiratory Tract Infection, Hypokalemia, Constipation, Asthenia, Nasopharyngitis, Bronchitis, Rash, Embolic and Thrombotic Events, Venous, Insomnia, Febrile Neutropenia, Lymphopenia, Cardiac Arrest, Cardiac Failure, Myocardial Infarction, Myocardial Ischemia, Cataract, Vision Blurred, Abdominal Pain, Dyspepsia, Toothache, Chills, Multi-organ Failure, Pain, Influenza, Sepsis, Urinary Tract Infection, Viral Infection, Dehydration, Hyperkalemia, Hyperuricemia, Hypoalbuminemia, Hyponatremia, Muscular Weakness, Myalgia, Hypoesthesia, Paresthesia, Deafness, Anxiety, Delirium, Renal Failure, Renal Failure Acute, Renal Impairment, Dysphonia, Epistaxis, Oropharyngeal Pain, Pulmonary Edema, Erythema, Hyperhidrosis, Pruritus, Deep Vein Thrombosis, Hypotension"
1,KYPROLIS,warnings and precautions,"Cardiac toxicities, cardiac failure, myocardial infarction, myocardial ischemia, death, Acute Renal Failure, renal impairment, renal failure, death, Tumor Lysis Syndrome, TLS, death, Pulmonary Toxicity, Acute Respiratory Distress Syndrome, acute respiratory failure, acute diffuse infiltrative pulmonary disease, pneumonitis, interstitial lung disease, death, Pulmonary Hypertension, PAH, death, Dyspnea, death, Hypertension, hypertensive crisis, hypertensive emergency, death, Venous Thrombosis, deep venous thrombosis, pulmonary embolism, Infusion Reactions, life-threatening reactions, Thrombocytopenia, Hepatic Toxicity, Hepatic Failure, hepatic failure, increased serum transaminases, death, Thrombotic Thrombocytopenic Purpura/Hemolytic Uremic Syndrome, TTP/HUS, death, Posterior Reversible Encephalopathy Syndrome, PRES, Reversible Posterior Leukoencephalopathy Syndrome, RPLS, Embryo-fetal Toxicity, fetal harm"
2,MULTAQ,adverse reactions,"New or worsening heart failure, death, liver injury, pulmonary toxicity, hypokalemia, hypomagnesemia, QT prolongation, diarrhea, nausea, abdominal pain, vomiting, asthenia, gastrointestinal disorders, premature discontinuation, QT prolongation, bradycardia, rashes, pruritus, eczema, dermatitis, dermatitis allergic, photosensitivity reaction, dysgeusia, early increases in creatinine, QTc prolongation, atrial flutter, interstitial lung disease, pneumonitis, pulmonary fibrosis, anaphylactic reactions, angioedema, vasculitis, leukocytoclastic vasculitis."
3,MULTAQ,boxed warnings,"death, stroke, heart failure"
4,MULTAQ,warnings and precautions,"Cardiovascular death, heart failure, stroke, new onset heart failure, worsening heart failure, liver injury, pulmonary toxicity, hypokalemia, hypomagnesemia, QT interval prolongation, renal impairment, renal failure, death."
5,JUBLIA,adverse reactions,"Ingrown toenails, Application site dermatitis, Application site vesicles, Application site pain, death"
6,TEFLARO,adverse reactions,"Hypersensitivity Reactions, Clostridium difficile-Associated diarrhea, Direct Coombs' Test Seroconversion, diarrhea, nausea, rash, death, constipation, vomiting, increased transaminases, hypokalemia, rash, phlebitis, anemia, eosinophilia, neutropenia, thrombocytopenia, bradycardia, palpitations, abdominal pain, pyrexia, hepatitis, hypersensitivity, anaphylaxis, Clostridium difficile colitis, hyperglycemia, hyperkalemia, dizziness, convulsion, renal failure, urticaria, agranulocytosis."
7,TEFLARO,warnings and precautions,"Serious hypersensitivity reactions, anaphylactic reactions, Clostridium difficile-associated diarrhea, CDAD, fatal colitis, direct Coombs' test seroconversion, drug-induced hemolytic anemia, death."
8,DATSCAN,adverse reactions,"Hypersensitivity, injection site reactions, headache, nausea, vertigo, dry mouth, dizziness, rash, pruritis, injection site pain"
9,DATSCAN,warnings and precautions,"Hypersensitivity reactions, Skin erythema, Pruritis, Anaphylactic reaction, Thyroid accumulation"
10,TIVICAY,adverse reactions,"Hypersensitivity reactions, Effects on serum liver biochemistries, Fat Redistribution, Immune Reconstitution Syndrome, insomnia, fatigue, headache, depression, abnormal dreams, dizziness, nausea, diarrhea, rash, vertigo, abdominal pain, abdominal discomfort, flatulence, upper abdominal pain, vomiting, hepatitis, myositis, suicidal ideation, suicidal attempt, suicidal behavior, suicidal completion, renal impairment, pruritus, elevated ALT, elevated AST, hyperglycemia, lipase elevation, total neutrophils elevation, elevated cholesterol, elevated creatine kinase, death."
11,TIVICAY,warnings and precautions,"Hypersensitivity reactions, rash, constitutional findings, organ dysfunction, liver injury, severe rash, fever, general malaise, fatigue, muscle or joint aches, blisters, peeling of the skin, oral blisters, lesions, conjunctivitis, facial edema, hepatitis, eosinophilia, angioedema, difficulty breathing, death, Transaminase elevations, immune reconstitution syndrome, hepatitis B reactivation, hepatotoxicity, Fat redistribution, body fat redistribution, central obesity, dorsocervical fat enlargement, buffalo hump, peripheral wasting, facial wasting, breast enlargement, ""cushingoid appearance"", Immune reconstitution syndrome, inflammatory response, opportunistic infections, Mycobacterium avium infection, cytomegalovirus, Pneumocystis jirovecii pneumonia, tuberculosis, autoimmune disorders, Graves' disease, polymyositis, Guillain-Barre syndrome"
12,TAFINLAR,adverse reactions,"New Primary Malignancies, Tumor Promotion in BRAF Wild-Type Melanoma, Hemorrhage, Venous Thromboembolism, Cardiomyopathy, Ocular Toxicities, Serious Febrile Reactions, Serious Skin Toxicity, Hyperglycemia, Glucose-6-Phosphate Dehydrogenase Deficiency, Death, Hyperkeratosis, Headache, Pyrexia, Arthralgia, Papilloma, Alopecia, Palmar-plantar erythrodysesthesia syndrome, Pyrexia, Chills, Fatigue, Rash, Nausea, Vomiting, Diarrhea, Abdominal pain, Peripheral edema, Cough, Headache, Arthralgia, Night sweats, Decreased appetite, Constipation, Myalgia, Pancreatitis, Hypersensitivity manifesting as bullous rash, Interstitial nephritis, Vision blurred, Transient blindness, Stomatitis, Asthenia, Cellulitis, Folliculitis, Paronychia, Rash pustular, Palmar-plantar erythrodysesthesia syndrome, Hyperhidrosis, Hypertension"
13,TAFINLAR,warnings and precautions,"Retinal vein occlusion, Interstitial lung disease, New primary malignancies, cutaneous malignancies, non-cutaneous malignancies, Tumor Promotion in BRAF Wild-Type Melanoma, Hemorrhage, Venous Thromboembolism, Cardiomyopathy, Ocular Toxicities, Serious Febrile Reactions, Serious Skin Toxicity, Hyperglycemia, Glucose-6-Phosphate Dehydrogenase Deficiency, Embryofetal Toxicity, death"
14,HORIZANT,adverse reactions,"Somnolence, sedation, dizziness, headache, nausea, dry mouth, flatulence, fatigue, irritability, feeling drunk, feeling abnormal, peripheral edema, weight increased, increased appetite, vertigo, depression, libido decreased, balance disorder, blurred vision, disorientation, lethargy, breast enlargement, gynecomastia, elevated creatine kinase."
15,HORIZANT,warnings and precautions,"Driving impairment, Somnolence, Sedation, Dizziness, Suicidal thoughts, Suicidal behaviors, Death, Lack of Interchangeability With Gabapentin, Drug Reaction With Eosinophilia and Systemic Symptoms (DRESS), Multiorgan Hypersensitivity"
16,IMBRUVICA,adverse reactions,"Hemorrhage, Infections, Cytopenias, Atrial Fibrillation, Second Primary Malignancies, Tumor Lysis Syndrome, death, thrombocytopenia, neutropenia, diarrhea, anemia, fatigue, musculoskeletal pain, bruising, nausea, upper respiratory tract infection, rash, pneumonia, abdominal pain, atrial fibrillation, constipation, dyspnea, vomiting, decreased appetite, urinary tract infection, skin infections, sinusitis, peripheral edema, pyrexia, asthenia, petechiae, muscle spasms, arthralgia, cough, epistaxis, dehydration, dizziness, headache, lymphocytosis, intracranial hemorrhage, lethargy, gait instability, hyperuricemia, subdural hematoma, infections, chills, laceration, anxiety, insomnia, hypertension, vision blurred, contusion, urticaria, angioedema."
17,IMBRUVICA,warnings and precautions,"Hemorrhage, bleeding, subdural hematoma, gastrointestinal bleeding, hematuria, post procedural hemorrhage, infections, fatal infections, progressive multifocal leukoencephalopathy, cytopenias, neutropenia, thrombocytopenia, anemia, atrial fibrillation, atrial flutter, second primary malignancies, non-skin carcinomas, non-melanoma skin cancer, tumor lysis syndrome, embryo-fetal toxicity, fetal harm, malformations, reduced fetal weights, death"
18,ULORIC,adverse reactions,"Liver function abnormalities, nausea, arthralgia, rash, death (from hepatic failure), dizziness, anemia, idiopathic thrombocytopenic purpura, leukocytosis/leukopenia, neutropenia, pancytopenia, splenomegaly, thrombocytopenia, angina pectoris, atrial fibrillation/flutter, cardiac murmur, ECG abnormal, palpitations, sinus bradycardia, tachycardia, deafness, tinnitus, vertigo, vision blurred, abdominal distention, abdominal pain, constipation, dry mouth, dyspepsia, flatulence, frequent stools, gastritis, gastroesophageal reflux disease, gastrointestinal discomfort, gingival pain, haematemesis, hyperchlorhydria, hematochezia, mouth ulceration, pancreatitis, peptic ulcer, vomiting, asthenia, chest pain/discomfort, edema, fatigue, feeling abnormal, gait disturbance, influenza-like symptoms, mass, pain, thirst, cholelithiasis/cholecystitis, hepatic steatosis, hepatitis, hepatomegaly, hypersensitivity, herpes zoster, contusion, anorexia, appetite decreased/increased, dehydration, diabetes mellitus, hypercholesterolemia, hyperglycemia, hyperlipidemia, hypertriglyceridemia, hypokalemia, weight decreased/increased, arthritis, joint stiffness, joint swelling, muscle spasms/twitching/tightness/weakness, musculoskeletal pain/stiffness, myalgia, altered taste, balance disorder, cerebrovascular accident, Guillain-Barre syndrome, headache, hemiparesis, hypoesthesia, hyposmia, lacunar infarction, lethargy, mental impairment, migraine, paresthesia, somnolence, transient ischemic attack, tremor, agitation, anxiety, depression, insomnia, irritability, libido decreased, nervousness, panic attack, personality change, hematuria, nephrolithiasis, pollakiuria, proteinuria, renal failure, renal insufficiency, urgency, incontinence, breast pain, erectile dysfunction, gynecomastia, bronchitis, cough, dyspnea, epistaxis, nasal dryness, paranasal sinus hypersecretion, pharyngeal edema, respiratory tract congestion, sneezing, throat irritation, upper respiratory tract infection, alopecia, angio-edema, dermatitis, dermographism, ecchymosis, eczema, hair color changes, hair growth abnormal, hyperhidrosis, peeling skin, petechiae, photosensitivity, pruritus, purpura, skin discoloration/altered pigmentation, skin lesion, skin odor abnormal, urticaria, flushing, hot flush, hypertension, hypotension, activated partial thromboplastin time prolonged, creatine increased, bicarbonate decreased, sodium increased, EEG abnormal, glucose increased, cholesterol increased, triglycerides increased, amylase increased, potassium increased, TSH increased, platelet count decreased, hematocrit decreased, hemoglobin decreased, MCV increased, RBC decreased, creatinine increased, blood urea increased, BUN/creatinine ratio increased, creatine phosphokinase (CPK) increased, alkaline phosphatase increased, LDH increased, PSA increased, urine output increased/decreased, lymphocyte count decreased, neutrophil count decreased, WBC increased/decreased, coagulation test abnormal, low density lipoprotein (LDL) increased, prothrombin time prolonged, urinary casts, urine positive for white blood cells and protein, death (from cardiovascular events), anaphylaxis, anaphylactic reaction, rhabdomyolysis, psychotic behavior including aggressive thoughts, tubulointerstitial nephritis, generalized rash, Stevens Johnson Syndrome, hypersensitivity skin reactions."
19,ULORIC,warnings and precautions,"Gout Flare, Cardiovascular Events, Hepatic Effects, liver injury, hepatic failure, fatal hepatic failure, transaminase elevations, abnormal liver tests, drug-induced liver injury, severe drug-induced liver injury, liver test abnormalities, liver test panel abnormalities, liver test abnormalities, death"
20,CIMZIA,adverse reactions,"upper respiratory tract infection, rash, urinary tract infection, serious infections, malignancies, heart failure, abdominal pain, diarrhea, intestinal obstruction, tuberculosis infections, pyrexia, urticaria, pneumonia, arthralgia, anemia, leukopenia, lymphadenopathy, pancytopenia, thrombophilia, angina pectoris, arrhythmias, atrial fibrillation, cardiac failure, hypertensive heart disease, myocardial infarction, myocardial ischemia, pericardial effusion, pericarditis, stroke, transient ischemic attack, optic neuritis, retinal hemorrhage, uveitis, bleeding, injection site reactions, elevated liver enzymes, hepatitis, alopecia totalis, anxiety, bipolar disorder, suicide attempt, nephrotic syndrome, renal failure, menstrual disorder, dermatitis, erythema nodosum, vasculitis, thrombophlebitis, systemic vasculitis, Stevens-Johnson syndrome, toxic epidermal necrolysis, erythema multiforme, sarcoidosis, death"
21,CIMZIA,boxed warnings,"Serious infections, Hospitalization, Death, Tuberculosis (TB), Bacterial sepsis, Invasive fungal infections, Histoplasmosis, Coccidioidomycosis, Candidiasis, Aspergillosis, Blastomycosis, Pneumocystosis, Opportunistic pathogens infections, Legionella, Listeria, Lymphoma, Malignancies."
22,CIMZIA,warnings and precautions,"serious infections, death, invasive fungal infections, lymphoma, heart failure, anaphylaxis, allergic reactions, hepatitis B virus reactivation, demyelinating disease, cytopenias, pancytopenia, lupus-like syndrome, neurologic reactions, hematological reactions, pancytopenia, aplastic anemia, autoimmunity"
23,KALYDECO,adverse reactions,"Transaminase Elevations, headache, oropharyngeal pain, upper respiratory tract infection, nasal congestion, abdominal pain, nasopharyngitis, diarrhea, rash, nausea, dizziness, increased hepatic enzymes, hypoglycemia, rhinitis, arthralgia, bacteria in sputum, aspartate aminotransferase increased, blood glucose increased, musculoskeletal chest pain, myalgia, sinus headache, pharyngeal erythema, pleuritic pain, sinus congestion, wheezing, acne."
24,KALYDECO,warnings and precautions,"Elevated transaminases, liver function abnormalities, Cataracts, Death"
25,FULYZAQ,adverse reactions,"Upper respiratory tract infection, bronchitis, cough, flatulence, increased bilirubin, nausea, back pain, arthralgia, urinary tract infection, nasopharyngitis, musculoskeletal pain, hemorrhoids, giardiasis, anxiety, increased alanine aminotransferase, abdominal distension, abdominal pain, acne, increased aspartate aminotransferase, increased conjugated bilirubin, increased unconjugated blood bilirubin, constipation, depression, dermatitis, dizziness, dry mouth, dyspepsia, gastroenteritis, herpes zoster, nephrolithiasis, pain in extremity, pollakiuria, procedural pain, seasonal allergy, sinusitis, decreased white blood cell count."
26,FULYZAQ,warnings and precautions,"diarrhea, infectious diarrhea, non-infectious diarrhea"
27,QUTENZA,adverse reactions,"Application-Associated Pain, Increase in Blood Pressure, Application site erythema, Application site pain, Application site pruritus, Application site papules, Application site edema, Application site swelling, Application site dryness, Nasopharyngitis, Bronchitis, Sinusitis, Nausea, Vomiting, Pruritus, Hypertension, Application site urticaria, Application site paresthesia, Application site dermatitis, Application site hyperesthesia, Application site excoriation, Application site warmth, Application site anesthesia, Application site bruising, Application site inflammation, Application site exfoliation, Peripheral edema, Headache, Burning sensation, Peripheral sensory neuropathy, Dizziness, Dysgeusia, Hyperesthesia, Hypoesthesia, Cough, Throat irritation, Abnormal skin odor"
28,QUTENZA,warnings and precautions,"Eye irritation, Mucous membrane irritation, Coughing, Sneezing, Skin irritation, Transient increases in blood pressure, Pain, Increase in blood pressure, Death."
29,GRANIX,adverse reactions,"Splenic Rupture, Acute Respiratory Distress Syndrome, Serious Allergic Reactions, Use in Patients with Sickle Cell Disease, Capillary Leak Syndrome, Potential for Tumor Growth Stimulatory Effects on Malignant Cells, Bone pain, Leukocytosis, Myalgia, Headache, Vomiting, Sweet's syndrome (acute febrile neutrophilic dermatosis), Cutaneous vasculitis, Thrombocytopenia"
30,GRANIX,warnings and precautions,"Splenic rupture, death, Acute Respiratory Distress Syndrome (ARDS), Allergic reactions, angioneurotic edema, dermatitis allergic, drug hypersensitivity, hypersensitivity, rash, pruritic rash, urticaria, death, Sickle cell crisis, death, Capillary Leak Syndrome, Tumor Growth Stimulatory Effects on Malignant Cells"
31,COARTEM,adverse reactions,"Headache, anorexia, dizziness, asthenia, arthralgia, myalgia, pyrexia, cough, vomiting, chills, fatigue, malaise, nausea, abdominal pain, diarrhea, sleep disorder, insomnia, palpitations, hepatomegaly, splenomegaly, anemia, pruritus, rash, vertigo, malaria, nasopharyngitis, rhinitis, Plasmodium falciparum infection, aspartate aminotransferase increased, eosinophilia, tinnitus, conjunctivitis, constipation, dyspepsia, dysphagia, peptic ulcer, gait disturbance, abscess, acrodermatitis, bronchitis, ear infection, gastroenteritis, helminthic infection, hookworm infection, impetigo, influenza, lower respiratory tract infection, oral herpes, pneumonia, respiratory tract infection, subcutaneous abscess, upper respiratory tract infection, urinary tract infection, alanine aminotransferase increased, hematocrit decreased, lymphocyte morphology abnormal, platelet count decreased, platelet count increased, white blood cell count decreased, white blood cell count increased, hypokalemia, back pain, ataxia, clonus, fine motor delay, hyperreflexia, hypoesthesia, nystagmus, tremor, agitation, mood swings, hematuria, proteinuria, asthma, pharyngo-laryngeal pain, urticaria, Death."
32,COARTEM,warnings and precautions,"QT prolongation, prolongation of the QT interval, long QT syndrome, sudden death, hypokalemia, hypomagnesemia, electrolyte imbalance, cardiac arrhythmias, bradycardia, severe cardiac disease, disturbances of electrolyte balance, class IA antiarrhythmic agents, class III antiarrhythmic agents, antipsychotics, antidepressants, macrolide antibiotics, fluoroquinolone antibiotics, imidazole antifungal agents, triazole antifungal agents, CYP2D6 substrates, CYP3A4 inhibitors, CYP3A4 inducers, antiretroviral medications, QT prolonging drugs, fatal event: death."
33,APTIOM,adverse reactions,"Suicidal Behavior, Ideation, Serious Dermatologic Reactions, Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS), Multiorgan Hypersensitivity, Anaphylactic Reactions, Angioedema, Hyponatremia, Neurological Adverse Reactions, Drug Induced Liver Injury, Abnormal Thyroid Function Tests, dizziness, somnolence, nausea, headache, diplopia, vomiting, fatigue, vertigo, ataxia, blurred vision, tremor, death"
34,APTIOM,warnings and precautions,"suicidal behavior, suicidal ideation, serious dermatologic reactions, drug reaction with eosinophilia and systemic symptoms (DRESS), anaphylactic reactions, angioedema, hyponatremia, neurological adverse reactions, dizziness, disturbance in gait and coordination, somnolence, fatigue, cognitive dysfunction, visual changes, death"
35,PROLIA,adverse reactions,"Hypocalcemia, Serious Infections, Dermatologic Adverse Reactions, Osteonecrosis of the Jaw, Atypical Subtrochanteric and Diaphyseal Femoral Fractures, death, back pain, pain in extremity, musculoskeletal pain, hypercholesterolemia, cystitis, arthralgia, nasopharyngitis, constipation, pancreatitis, anemia, angina pectoris, atrial fibrillation, vertigo, abdominal pain upper, flatulence, gastroesophageal reflux disease, edema peripheral, asthenia, upper respiratory tract infection, pneumonia, pharyngitis, herpes zoster, bone pain, myalgia, spinal osteoarthritis, sciatica, insomnia, rash, pruritus, decreases in serum calcium levels, serious infections, epidermal and dermal adverse events, ONJ (Osteonecrosis of the Jaw), atypical femoral fractures, new malignancies, cataracts, drug-related hypersensitivity reactions (anaphylaxis, urticaria, facial swelling, erythema), severe symptomatic hypocalcemia, marked elevation in serum PTH, and musculoskeletal pain."
36,PROLIA,warnings and precautions,"Hypersensitivity, anaphylactic reactions, Hypocalcemia, Osteonecrosis of the jaw, Atypical femoral fractures, Serious infections, Skin infections, Endocarditis, Dermatitis, Rashes, Eczema, Severe Bone, Joint, Muscle Pain, Suppression of bone turnover"
37,BLINCYTO,adverse reactions,"Cytokine Release Syndrome, Neurological Toxicities, Infections, Tumor Lysis Syndrome, Neutropenia, Febrile Neutropenia, Effects on Ability to Drive and Use Machines, Elevated Liver Enzymes, Leukoencephalopathy, Preparation and Administration Errors, pyrexia, headache, peripheral edema, febrile neutropenia, nausea, hypokalemia, tremor, rash, constipation, death, pneumonia, sepsis, device-related infection, encephalopathy, overdose, confusion, Staphylococcal bacteremia, anemia, thrombocytopenia, leukopenia, diarrhea, abdominal pain, vomiting, fatigue, chills, chest pain, cytokine release syndrome, other pathogen infections, bacterial infections, fungal infections, viral infections, increased alanine aminotransferase, increased aspartate aminotransferase, increased weight, hypokalemia, hypomagnesemia, hyperglycemia, decreased appetite, hypophosphatemia, back pain, pain in extremity, bone pain, arthralgia, tremor, dizziness, insomnia, cough, dyspnea, rash, hypotension, hypertension, leukocytosis, lymphopenia, tachycardia, edema, cytokine storm, decreased immunoglobulins, increased blood bilirubin, increased gamma-glutamyl-transferase, increased liver enzymes, tumor lysis syndrome, hypoalbuminemia, encephalopathy, paresthesia, aphasia, convulsion, memory impairment, cognitive disorder, speech disorder, confusion, disorientation, capillary leak syndrome, hypersensitivity, bronchospasm."
38,BLINCYTO,boxed warnings,"Cytokine Release Syndrome (CRS), death, Neurological toxicities, death"
39,BLINCYTO,warnings and precautions,"Infections, sepsis, pneumonia, bacteremia, opportunistic infections, catheter-site infections, death, Cytokine Release Syndrome (CRS), pyrexia, headache, nausea, asthenia, hypotension, increased alanine aminotransferase, increased aspartate aminotransferase, increased total bilirubin, disseminated intravascular coagulation (DIC), capillary leak syndrome (CLS), hemophagocytic lymphohistiocytosis/macrophage activation syndrome (HLH/MAS), death, Neurological Toxicities, encephalopathy, convulsions, speech disorders, disturbances in consciousness, confusion, disorientation, coordination and balance disorders, death, Serious Infections, sepsis, pneumonia, bacteremia, opportunistic infections, catheter-site infections, death, Tumor Lysis Syndrome (TLS), death, Neutropenia, febrile neutropenia, death, Elevated Liver Enzymes, alanine aminotransferase (ALT), aspartate aminotransferase (AST), gamma-glutamyl transferase (GGT), total blood bilirubin, death, Leukoencephalopathy, Preparation and Administration Errors"
40,STENDRA,adverse reactions,"Headache, death, Flushing, Nasal congestion, Nasopharyngitis, Back pain, Upper respiratory infection (URI), Bronchitis, Influenza, Sinusitis, Sinus congestion, Hypertension, Dyspepsia, Nausea, Constipation, Rash, Dizziness, Arthralgia, Diarrhea, Edema peripheral, Fatigue, Angina, Unstable angina, Deep vein thrombosis, Palpitations, Gastritis, Gastroesophageal reflux disease, Hypoglycemia, Increased blood glucose, Increased alanine aminotransferase, Oropharyngeal pain, Stomach discomfort, Vomiting, Muscle spasms, Musculoskeletal pain, Myalgia, Pain in extremity, Depression, Insomnia, Somnolence, Vertigo, Cough, Dyspnea exertional, Epistaxis, Wheezing, Pruritus, Balanitis, Erection increased, Hematuria, Nephrolithiasis, Pollakiuria, Urinary tract infection, Electrocardiogram abnormal, Non-arteritic anterior ischemic optic neuropathy (NAION)"
41,STENDRA,warnings and precautions,"hypotension, erection lasting greater than 4 hours, sudden loss of vision, Non Arteritic Ischemic Optic Neuropathy (NAION), sudden decrease or loss of hearing, prolonged erection, priapism, anatomical deformation of the penis, penile tissue damage, permanent loss of potency, sudden loss of vision in one or both eyes, non-arteritic anterior ischemic optic neuropathy (NAION), sudden hearing loss, sudden decrease or loss of hearing, dizziness, lightheadedness, fainting, symptomatic hypotension, orthostatic signs and symptoms, increase in heart rate, decrease in standing blood pressure, headache, bleeding disorders, active peptic ulceration."
42,XIAFLEX,adverse reactions,"Tendon ruptures, serious injury, flexor tendon rupture, corporal rupture, penile fracture, severe penile hematoma, penile ecchymoses, sudden penile detumescence, penile ""popping"" sound or sensation, edema peripheral, swelling of the injected hand, contusion, injection site hemorrhage, injection site reaction, pain in the injected extremity, penile swelling, penile pain, penile hematoma, penile ecchymoses, blood blister, injection site pain, lymphadenopathy, skin laceration, lymph node pain, erythema, axillary pain, pruritus, vasovagal syncope, penile ""popping"" sounds or sensations, death."
43,XIAFLEX,boxed warnings,"Corporal rupture, Penile fracture, Penile injury, Penile ecchymoses, Penile hematoma, Sudden penile detumescence, Penile ""popping"" sound or sensation"
44,XIAFLEX,warnings and precautions,"Tendon rupture, serious injury, ligament damage, skin laceration, pulley rupture, complex regional pain syndrome (CRPS), sensory abnormality, hypersensitivity reactions, anaphylaxis, pruritus, allergic reactions, corporal rupture (penile fracture), penile ecchymoses, hematoma, penile detumescence, penile ""popping"" sensation, severe penile hematoma, bleeding, ecchymosis, contusion, injection site hemorrhage, penile hematoma."
45,XEOMIN,adverse reactions,"Hypersensitivity, death, dysphagia, breathing difficulties, spread of effects from toxin, neck pain, muscle weakness, injection site pain, musculoskeletal pain, eyelid ptosis, dry eye, dry mouth, diarrhea, headache, visual impairment, dyspnea, nasopharyngitis, respiratory tract infection, eye disorders, facial paresis, injection site hematoma, eyelid edema, facial pain, injection site swelling, sensation of pressure, facial paresis (brow ptosis), muscle disorder (elevation of eyebrow), eye swelling, nausea, flu-like symptoms, allergic dermatitis, localized allergic reactions like swelling, edema, erythema, pruritus or rash, herpes zoster, muscular weakness, muscle spasm, dysarthria, myalgia."
46,XEOMIN,boxed warnings,"Asthenia, Generalized muscle weakness, Diplopia, Blurred vision, Ptosis, Dysphagia, Dysphonia, Dysarthria, Urinary incontinence, Breathing difficulties, Death"
47,XEOMIN,warnings and precautions,"respiratory difficulties, speech difficulties, swallowing difficulties, dysphagia, dysphonia, dysarthria, asthenia, generalized muscle weakness, diplopia, blurred vision, ptosis, urinary incontinence, breathing difficulties, death, corneal exposure, corneal ulceration, reduced blinking, ulceration, perforation, ectropion, ecchymosis, ptosis"
48,GILOTRIF,adverse reactions,"Diarrhea, Bullous and Exfoliative Skin Disorders, Interstitial Lung Disease, Hepatic Toxicity, Keratitis, rash/dermatitis acneiform, stomatitis, paronychia, dry skin, decreased appetite, nausea, vomiting, pruritus, death, pulmonary toxicity/ILD-like adverse reactions, sepsis, pneumonia, ventricular dysfunction, diastolic dysfunction, left ventricular dysfunction, ventricular dilation, stomatitis, aphthous stomatitis, mucosal inflammation, mouth ulceration, oral mucosa erosion, mucosal erosion, mucosal ulceration, acne, acne pustular, dermatitis acneiform, paronychia, nail infection, nail bed infection, cheilitis, cystitis, epistaxis, rhinorrhea, weight decreased, pyrexia, conjunctivitis, Alanine aminotransferase increased, Hypokalemia, Aspartate aminotransferase increased, Pancreatitis"
49,GILOTRIF,warnings and precautions,"Diarrhea, dehydration, renal failure, death, Bullous skin disorders, exfoliative skin disorders, bullous lesions, blistering lesions, exfoliating lesions, cutaneous reactions, rash, erythema, acneiform rash, palmar-plantar erythrodysesthesia syndrome, Interstitial lung disease, ILD, lung infiltration, pneumonitis, acute respiratory distress syndrome, alveolitis allergic, death, Hepatic toxicity, hepatic impairment, liver test abnormalities, fatal hepatic impairment, severe liver tests, worsening liver tests, severe hepatic impairment, death, Keratitis, eye inflammation, lacrimation, light sensitivity, blurred vision, eye pain, red eye, ulcerative keratitis, death, Embryofetal toxicity, fetal harm, embryotoxic, abortions, pregnancy, hazard to fetus, highly effective contraception."
50,TREANDA,adverse reactions,"Myelosuppression, Infections, Anaphylaxis, Infusion Reactions, Tumor Lysis Syndrome, Skin Reactions, Other Malignancies, Extravasation injury, pyrexia, nausea, vomiting, diarrhea, fatigue, constipation, anorexia, cough, headache, weight decreased, dyspnea, rash, stomatitis, lymphopenia, anemia, leukopenia, thrombocytopenia, neutropenia, hypertension, hypersensitivity, bilirubin elevations, AST, ALT, creatinine levels, death, febrile neutropenia, pneumonia, hypokalemia, dehydration, tachycardia, abdominal pain, dyspepsia, gastroesophageal reflux disease, dry mouth, abdominal distension, chills, edema peripheral, chest pain, infusion site pain, pain, catheter site pain, herpes zoster, upper respiratory tract infection, urinary tract infection, sinusitis, oral candidiasis, nasopharyngitis, weight decreased, anorexia, decreased appetite, hyperuricemia, back pain, arthralgia, pain in extremity, bone pain, headache, dizziness, dysgeusia, insomnia, anxiety, depression, cough, dyspnea, pharyngolaryngeal pain, wheezing, nasal congestion, pruritus, dry skin, night sweats, hyperhidrosis, hypotension, hyperglycemia, hyponatremia, hypocalcemia, acute renal failure, cardiac failure, pulmonary fibrosis, myelodysplastic syndrome, hemolysis, taste disorder, atypical pneumonia, sepsis, herpes zoster, erythema, dermatitis, skin necrosis, SJS, TEN, phlebitis, irritation, pain, swelling, pneumocystis jiroveci pneumonia, pneumonitis, death."
51,TREANDA,warnings and precautions,"Myelosuppression, death, infections, anaphylaxis, infusion reactions, tumor lysis syndrome, acute renal failure, skin reactions, SJS, TEN, fatal, other malignancies, extravsation, embryo-fetal toxicity"
52,CHOLINE,adverse reactions,"injection site reaction, death"
53,CHOLINE,warnings and precautions,"Imaging errors, false positive results, false negative results, tissue inflammation, prostatic hyperplasia, concomitant use of colchicine, androgen-deprivation drugs, allergic reactions, anaphylaxis, radiation exposure, increased risk for cancer, death."
54,ERWINAZE,adverse reactions,"Hypersensitivity reactions, death, pancreatitis, glucose intolerance, thrombosis, hemorrhage, systemic hypersensitivity, hyperglycemia, transaminases abnormal, fever, local reactions, vomiting, nausea, hyperbilirubinemia, abdominal pain/discomfort, diarrhea"
55,ERWINAZE,warnings and precautions,"Serious hypersensitivity reactions, anaphylaxis, Severe or hemorrhagic pancreatitis, Glucose intolerance, Thrombosis, hemorrhage, Death"
56,TRULICITY,adverse reactions,"Thyroid C-cell Tumors, Pancreatitis, Hypoglycemia, Insulin Secretagogues, Insulin, Hypersensitivity reactions, Renal impairment, Severe Gastrointestinal Disease, nausea, diarrhea, vomiting, abdominal pain, decreased appetite, death, constipation, flatulence, abdominal distension, gastroesophageal reflux disease, eructation, hypoglycemia, heart rate increase, tachycardia, sinus tachycardia, immunogenicity, anti-drug antibodies, dulaglutide, GLP-1, hypersensitivity, urticaria, systemic rash, facial edema, lip swelling, injection-site reactions, PR interval prolongation, first degree atrioventricular block, amylase increase, lipase increase."
57,TRULICITY,boxed warnings,"Thyroid C-cell tumors, Medullary thyroid carcinoma (MTC), Mass in the neck, Dysphagia, Dyspnea, Persistent hoarseness, Death"
58,TRULICITY,warnings and precautions,"Thyroid C-cell tumors, death, Pancreatitis, Hypoglycemia, Hypersensitivity reactions, Renal impairment, Severe gastrointestinal disease"
59,ADREVIEW,adverse reactions,"Serious hypersensitivity reactions, Dizziness, Rash, Pruritis, Flushing, Headache, Injection site hemorrhage"
60,ADREVIEW,warnings and precautions,"Hypersensitivity reactions, anaphylactic reactions, serious reactions, benzyl alcohol toxicity, Gasping Syndrome, toxicity, kernicterus, death, increased radiation exposure, decreased quality of images, thyroid neoplasia, hypertension"
61,DOTAREM,adverse reactions,"NSF, Hypersensitivity reactions, Acute kidney injury, Nausea, Headache, Injection site pain, Injection site coldness, Burning sensation, Feeling cold, Rash, Somnolence, Fatigue, Dizziness, Vomiting, Pruritus, Paresthesia, Dysgeusia, Pain in extremity, Anxiety, Hypertension, Palpitations, Oropharyngeal discomfort, Serum creatinine increased, Injection site reactions, Bradycardia, Tachycardia, Arrhythmia, Anaphylactoid reactions, Cardiac arrest, Respiratory arrest, Cyanosis, Pharyngeal edema, Laryngospasm, Bronchospasm, Angioedema, Conjunctivitis, Ocular hyperemia, Eyelid edema, Lacrimation increased, Hyperhidrosis, Urticaria, Coma, Convulsion, Syncope, Presyncope, Parosmia, Tremor, Muscle contracture, Muscle weakness, Diarrhea, Salivary hypersecretion, Malaise, Fever, NSF, Superficial phlebitis, Death"
62,DOTAREM,boxed warnings,"Nephrogenic systemic fibrosis, NSF, fatal event, death, fibrosis, skin fibrosis, muscle fibrosis, internal organ fibrosis, chronic kidney disease, severe kidney disease, acute kidney injury, impaired elimination, gadolinium-based contrast agents, GBCAs, renal function, glomerular filtration rate, DOTAREM dose."
63,DOTAREM,warnings and precautions,"Nephrogenic Systemic Fibrosis, NSF, Hypersensitivity, Anaphylactoid reactions, Anaphylactic reactions, Cardiovascular manifestations, Respiratory manifestations, Cutaneous manifestations, Death, Acute Kidney Injury, Extravasation, Injection Site Reactions"
64,PRADAXA,adverse reactions,"bleeding, gastrointestinal events, dyspepsia, nausea, upper abdominal pain, gastrointestinal hemorrhage, diarrhea, intracranial hemorrhage, hemorrhagic stroke, other ICH, fatal bleeding, ICH, non-intracranial, any gastrointestinal bleeds, gastritis-like symptoms, GERD, esophagitis, erosive gastritis, gastric hemorrhage, hemorrhagic gastritis, hemorrhagic erosive gastritis, gastrointestinal ulcer, drug hypersensitivity, urticaria, rash, pruritus, allergic edema, anaphylactic reaction, anaphylactic shock, angioedema, thrombocytopenia, esophageal ulcer, death"
65,PRADAXA,boxed warnings,"THROMBOTIC EVENTS, SPINAL/EPIDURAL HEMATOMA, DEATH"
66,PRADAXA,warnings and precautions,"bleeding, death, blood loss, thrombotic events, significant bleeding, fatal bleeding, spinal or epidural hematoma, paralysis, major bleeding, neurological impairment, valve thrombosis, stroke, transient ischemic attack, myocardial infarction, post-operative pericardial effusions, P-gp inducers reducing exposure to dabigatran, increased exposure to dabigatran, risk of stroke and systemic embolism, deep venous thrombosis, pulmonary embolism"
67,ELIQUIS,adverse reactions,"Thrombotic events, Bleeding, Spinal/epidural anesthesia or puncture, death, Major bleeding, Intracranial bleed, Hemorrhagic stroke, Other ICH, Gastrointestinal bleed, Fatal bleeding, Intracranial, Non-intracranial, Hypersensitivity reactions, Drug hypersensitivity, Skin rash, Anaphylactic reactions, Allergic edema, Syncope, Major bleeding, Intracranial, Hemorrhagic stroke, Other ICH, Gastrointestinal, Fatal, Intracranial, Non-intracranial, Major bleeding, CRNM, Epistaxis, Contusion, Hemorrhage, Hematoma, Vaginal hemorrhage, Urethral hemorrhage, Postprocedural hemorrhage, Postprocedural hematoma, Wound hemorrhage, Vessel puncture site hematoma, Catheter site hemorrhage, Transaminases increased, Alanine aminotransferase increased, Alanine aminotransferase abnormal, Aspartate aminotransferase increased, Gamma-glutamyltransferase increased, Thrombocytopenia, Hypotension, Gastrointestinal hemorrhage, Hematemesis, Melena, Hematuria, Liver function test abnormal, Blood alkaline phosphatase increased, Blood bilirubin increased, Wound secretion, Incision-site hemorrhage, Operative hemorrhage, Gingival bleeding, Hemoptysis, Muscle hemorrhage, Ocular hemorrhage, Conjunctival hemorrhage, Rectal hemorrhage, DVT, PE, Recurrence of DVT or PE, Gingival bleeding, Epistaxis, Contusion, Hematuria, Rectal hemorrhage, Hematoma, Menorrhagia, Hemoptysis, Major bleeding, CRNM, Epistaxis, Contusion, Hematuria, Menorrhagia, Hematoma, Hemoptysis, Rectal hemorrhage, Gingival bleeding, Major bleeding, CRNM, Minor, Epistaxis, Contusion, Hematuria, Menorrhagia, Hematoma, Hemoptysis, Rectal hemorrhage, Gingival bleeding, Major bleeding, CRNM, Minor, Epistaxis, Hematuria, Hematoma, Contusion, Gingival bleeding, Hematochezia, Hemorrhoidal hemorrhage, Gastrointestinal hemorrhage, Hematemesis, Melena, Anal hemorrhage, Wound hemorrhage, Postprocedural hemorrhage, Traumatic hematoma, Periorbital hematoma, Muscle hemorrhage, Vaginal hemorrhage, Metrorrhagia, Menometrorrhagia, Genital hemorrhage, Hemorrhage, Ecchymosis, Skin hemorrhage, Petechiae, Conjunctival hemorrhage, Retinal hemorrhage, Eye hemorrhage, Blood urine present, Occult blood positive, Occult blood, Red blood cells urine positive, Injection-site hematoma, Vessel puncture-site hematoma."
68,ELIQUIS,boxed warnings,"Thrombotic events, Spinal/epidural hematoma, Paralysis, Neurological impairment"
69,ELIQUIS,warnings and precautions,"serious bleeding, potentially fatal bleeding, blood loss, stroke, bleeding, pathological bleeding, active pathological hemorrhage, epidural hematoma, spinal hematoma, paralysis, neurological impairment, numbness, weakness, bowel dysfunction, bladder dysfunction, death"
70,ZERBAXA,adverse reactions,"Hypersensitivity reactions, Clostridium difficile-associated diarrhea, Nausea, Diarrhea, Headache, Pyrexia, Constipation, Insomnia, Vomiting, Hypokalemia, ALT increased, AST increased, Anemia, Thrombocytosis, Abdominal pain, Anxiety, Dizziness, Hypotension, Atrial fibrillation, Rash, Cardiac disorders: tachycardia, angina pectoris, Gastrointestinal disorders: ileus, gastritis, abdominal distension, dyspepsia, flatulence, ileus paralytic, General disorders and administration site conditions: infusion site reactions, Infections and infestations: candidiasis, oropharyngeal, fungal urinary tract infection, Investigations: increased serum gamma-glutamyl transpeptidase (GGT), increased serum alkaline phosphatase, positive Coombs test, Metabolism and nutrition disorders: hyperglycemia, hypomagnesemia, hypophosphatemia, Nervous system disorders: ischemic stroke, Renal and urinary system: renal impairment, renal failure, Respiratory, thoracic and mediastinal disorders: dyspnea, Skin and subcutaneous tissue disorders: urticaria, Vascular disorders: venous thrombosis, Death"
71,ZERBAXA,warnings and precautions,"Decreased efficacy, Serious hypersensitivity reactions, Anaphylactic reactions, Clostridium difficile-associated diarrhea, Fatal colitis, Death."
72,FERRIPROX,adverse reactions,"chromaturia, nausea, vomiting, abdominal pain, alanine aminotransferase increased, arthralgia, neutropenia, agranulocytosis, decreased plasma zinc concentrations, diarrhea, dyspepsia, weight increased, aspartate aminotransferase increased, increased appetite, decreased appetite, back pain, pain in extremity, arthropathy, headache, neutrophil count decreased, thrombocytosis, pancytopenia, atrial fibrillation, cardiac failure, hypospadias, diplopia, papilledema, retinal toxicity, enterocolitis, rectal hemorrhage, gastric ulcer, pancreatitis, parotid gland enlargement, chills, pyrexia, edema peripheral, multi-organ failure, jaundice, hepatomegaly, anaphylactic shock, hypersensitivity, cryptococcal cutaneous infection, enteroviral encephalitis, pharyngitis, pneumonia, sepsis, furuncle, infectious hepatitis, rash pustular, subcutaneous abscess, blood bilirubin increased, blood creatinine phosphokinase increased, metabolic acidosis, dehydration, myositis, chondropathy, trismus, cerebellar syndrome, cerebral hemorrhage, convulsion, gait disturbance, intracranial pressure increased, psychomotor skills impaired, pyramidal tract syndrome, somnolence, bruxism, depression, obsessive-compulsive disorder, glycosuria, hemoglobinuria, acute respiratory distress syndrome, epistaxis, hemoptysis, pulmonary embolism, hyperhidrosis, periorbital edema, photosensitivity reaction, pruritis, urticaria, rash, Henoch-Schonlein purpura, hypotension, hypertension, death."
73,FERRIPROX,boxed warnings,"Agranulocytosis, Neutropenia, Serious infections, Death"
74,FERRIPROX,warnings and precautions,"Agranulocytosis, Neutropenia, Death, Embryofetal Toxicity"
75,DALVANCE,adverse reactions,"Nausea, vomiting, diarrhea, headache, rash, pruritus, Anemia, hemorrhagic anemia, leucopenia, neutropenia, thrombocytopenia, petechiae, eosinophilia, thrombocytosis, Gastrointestinal hemorrhage, melena, hematochezia, abdominal pain, Infusion-related reactions, Hepatotoxicity, Anaphylactoid reaction, Clostridium difficile colitis, oral candidiasis, vulvovaginal mycotic infection, Hepatic transaminases increased, blood alkaline phosphatase increased, international normalized ratio increased, Hypoglycemia, Dizziness, Bronchospasm, Urticaria, Flushing, phlebitis, wound hemorrhage, spontaneous hematoma, death."
76,DALVANCE,warnings and precautions,"Hypersensitivity reactions, anaphylactic reactions, skin reactions, Infusion-related reactions, Hepatic effects, ALT elevations, Clostridium difficile-associated diarrhea, CDAD, fatal colitis, Development of drug-resistant bacteria"
77,ARCAPTA,adverse reactions,"asthma-related death, death, cough, oropharyngeal pain, nasopharyngitis, headache, nausea, COPD exacerbation, pneumonia, angina pectoris, atrial fibrillation, muscle spasm, musculoskeletal pain, edema peripheral, diabetes mellitus, hyperglycemia, sinusitis, upper respiratory tract infection, hypersensitivity reactions, paradoxical bronchospasm, tachycardia/heart rate increase/palpitations, pruritus/rash, dizziness"
78,ARCAPTA,boxed warnings,"Asthma-related death, Death"
79,ARCAPTA,warnings and precautions,"asthma-related death, death, immediate hypersensitivity reactions, life-threatening paradoxical bronchospasm, paradoxical bronchospasm, cardiovascular effects, convulsive disorders, thyrotoxicosis, sensitivity to sympathomimetic drugs, hypokalemia, hyperglycemia"
80,CERDELGA,adverse reactions,"Fatigue, Headache, Nausea, Diarrhea, Back pain, Pain in extremities, Upper abdominal pain, Arthralgia, Migraine, Flatulence, Oropharyngeal pain, Dizziness, Asthenia, Cough, Dyspepsia, Gastroesophageal reflux disease, Constipation, Palpitations, Rash, Death"
81,CERDELGA,warnings and precautions,"ECG Changes, Cardiac Arrhythmias, Prolongation of PR interval, Prolongation of QTc interval, Prolongation of QRS interval"
82,GADAVIST,adverse reactions,"Nephrogenic Systemic Fibrosis, death, Hypersensitivity reactions, anaphylactic shock, circulatory collapse, respiratory arrest, pulmonary edema, bronchospasm, cyanosis, oropharyngeal swelling, laryngeal edema, blood pressure increased, chest pain, angioedema, conjunctivitis, hyperhidrosis, cough, sneezing, burning sensation, pallor, headache, nausea, dizziness, dysgeusia, feeling hot, injection site reactions, vomiting, rash, pruritus, erythema, dyspnea, paresthesia, loss of consciousness, convulsion, parosmia, tachycardia, palpitation, dry mouth, malaise, feeling cold."
83,GADAVIST,boxed warnings,"Nephrogenic systemic fibrosis, death"
84,GADAVIST,warnings and precautions,"Nephrogenic Systemic Fibrosis, Anaphylactic reactions, Hypersensitivity reactions, Cardiovascular manifestations, Respiratory manifestations, Cutaneous manifestations, Death"
85,ZYKADIA,adverse reactions,"Severe or Persistent Gastrointestinal Toxicity, Hepatotoxicity, Interstitial Lung Disease/Pneumonitis, QT Interval Prolongation, Hyperglycemia, Bradycardia, Pancreatitis, diarrhea, nausea, elevated transaminases, vomiting, abdominal pain, fatigue, decreased appetite, constipation, death, convulsion, pneumonia, ILD/pneumonitis, dyspnea, dehydration, hyperglycemia, increased ALT, increased AST, serious adverse drug reactions, fatal adverse reactions, respiratory failure, pneumothorax, gastric hemorrhage, general physical health deterioration, pulmonary tuberculosis, cardiac tamponade, sepsis, decreased appetite, neuropathy, vision disorder, prolonged QT interval, bradycardia, hemoglobin decreased, creatinine increased, glucose increased, phosphate decreased, lipase increased, bilirubin (total) increased."
86,ZYKADIA,warnings and precautions,"Severe or Persistent Gastrointestinal Toxicity, diarrhea, nausea, vomiting, abdominal pain, death, Hepatotoxicity, Interstitial Lung Disease (ILD), Pneumonitis, QT Interval Prolongation, death, Hyperglycemia, Bradycardia, Pancreatitis, death, Embryofetal Toxicity"
87,XALKORI,adverse reactions,"Hepatotoxicity, Interstitial Lung Disease, Pneumonitis, QT Interval Prolongation, Bradycardia, Severe Visual Loss, Vision Disorders, Diarrhea, Nausea, Vomiting, Constipation, Edema, Elevated Transaminases, Upper Respiratory Infection, Decreased Appetite, Dysgeusia, Dyspepsia, Dysphagia, Abdominal Pain, Pyrexia, Weight Increased, Pain in Extremity, Muscle Spasm, Dizziness, Headache, Fatigue, Neuropathy, Rash, Renal Cyst, Syncope, Weight Decreased, Pneumonia, Pulmonary Embolism, Dyspnea, ILD (Interstitial Lung Disease), Syncope, Electrocardiogram QT Prolonged, ALT Elevation, AST Elevation, Hypophosphatemia, Lymphopenia, Neutropenia, Hypokalemia, Death (due to septic shock, acute respiratory failure, diabetic ketoacidosis, acute respiratory distress syndrome, arrhythmia, pneumonia, pneumonitis, pulmonary embolism, respiratory failure, sepsis)."
88,XALKORI,warnings and precautions,"Hepatotoxicity, liver toxicity, elevated transaminases, interstitial lung disease, ILD, pneumonitis, QT interval prolongation, prolonged QTc, bradycardia, slow heart rate, severe visual loss, vision loss, optic atrophy, optic nerve disorder, embryofetal toxicity, fetal harm, death"
89,BEPREVE,adverse reactions,"mild taste following instillation, eye irritation, headache, nasopharyngitis, itching, body rash, swelling of lips, swelling of tongue, swelling of throat, death"
90,BEPREVE,warnings and precautions,"Contamination, Irritation, Redness, Absorption, Death"
91,EDARBI,adverse reactions,"Diarrhea, death, Hypotension/orthostatic hypotension, Nausea, Asthenia, fatigue, Muscle spasm, Dizziness, dizziness postural, Cough, Rash, Pruritus, Angioedema"
92,EDARBI,boxed warnings,"Fetal toxicity, Injury to the developing fetus, Death"
93,EDARBI,warnings and precautions,"Fetal Toxicity, Death, Hypotension, Renal Impairment, Renal Failure, Oligohydramnios, Neonatal Morbidity, Skull Hypoplasia, Anuria, Volume Depletion, Salt Depletion, Skeletal Deformations, Renal Function Changes, Azotemia, Acute Renal Failure, Death"
94,POTIGA,adverse reactions,"Retinal abnormalities, potential vision loss, urinary retention, skin discoloration, neuropsychiatric symptoms, dizziness, somnolence, QT interval effect, suicidal behavior, ideation, withdrawal seizures, death, fatigue, confusional state, vertigo, tremor, abnormal coordination, diplopia, disturbance in attention, memory impairment, asthenia, blurred vision, gait disturbance, aphasia, dysarthria, balance disorder, nausea, constipation, dyspepsia, influenza, weight increased, dizziness, somnolence, memory impairment, tremor, vertigo, abnormal coordination, disturbance in attention, gait disturbance, aphasia, dysarthria, balance disorder, paresthesia, amnesia, dysphasia, confusional state, anxiety, disorientation, psychotic disorder, dysuria, urinary hesitation, hematuria, chromaturia, increased appetite, hallucinations, myoclonus, peripheral edema, hypokinesia, dry mouth, dysphagia, hyperhidrosis, urinary retention, malaise, increased liver enzymes, rash, nystagmus, dyspnea, leukopenia, muscle spasms, alopecia, nephrolithiasis, syncope, neutropenia, thrombocytopenia, euphoric mood, renal colic, coma, encephalopathy."
95,POTIGA,boxed warnings,"Retinal abnormalities, vision loss, abnormal visual acuity, retinal pigmentary abnormalities, vision changes, death"
96,POTIGA,warnings and precautions,"Urinary retention, skin discoloration, retinal abnormalities, vision loss, confusional state, psychotic symptoms, hallucinations, dizziness, somnolence, QT prolongation, suicidal thoughts, suicidal behavior, death."
97,TUDORZA,adverse reactions,"Paradoxical bronchospasm, Worsening of narrow-angle glaucoma, Worsening of urinary retention, Immediate Hypersensitivity Reactions, headache, nasopharyngitis, cough, diarrhea, sinusitis, rhinitis, toothache, fall, vomiting, diabetes mellitus, dry mouth, 1st degree AV block, osteoarthritis, cardiac failure, cardio-respiratory arrest, anaphylaxis, angioedema, urticaria, rash, itching."
98,TUDORZA,warnings and precautions,"Paradoxical bronchospasm, Worsening of narrow-angle glaucoma, Worsening of urinary retention, Immediate hypersensitivity reactions (including angioedema, bronchospasm, anaphylaxis), Death"
99,PROMACTA,adverse reactions,"Hepatic Decompensation, Hepatotoxicity, Thrombotic/Thromboembolic Complications, Cataracts, Nausea, Diarrhea, Upper respiratory tract infection, Vomiting, Increased ALT, Myalgia, Urinary tract infection, Anemia, Pyrexia, Fatigue, Headache, Decreased appetite, Influenza-like illness, Asthenia, Insomnia, Cough, Pruritus, Chills, Alopecia, Peripheral edema, Hyperbilirubinemia, Back pain, Paresthesia, Rash, Oropharyngeal pain, Increased AST, Pharyngitis, Influenza, Alopecia, Musculoskeletal pain, Blood alkaline phosphatase increased, Dry mouth, Toothache, Vitamin D deficiency, Abdominal pain, AST increased, ALT increased, Thrombotic microangiopathy with acute renal failure, Pain in extremity, Dyspnea, Dizziness, Febrile neutropenia, Ecchymosis, Muscle spasms, Arthralgia, Rhinorrhea, Transaminases increased, Bone marrow aspirates abnormalities, Death."
100,PROMACTA,boxed warnings,"Hepatic decompensation, Liver decompensation"
101,PROMACTA,warnings and precautions,"Hepatotoxicity, liver enzyme elevations, hepatic decompensation, ascites, encephalopathy, indirect hyperbilirubinemia, abnormal serum liver tests, liver injury, thrombotic events, portal vein thrombosis, thrombotic/thromboembolic complications, venous events, arterial events, thromboembolism, thrombotic complications, Factor V Leiden, ATIII deficiency, antiphospholipid syndrome, cataracts"
102,INLYTA,adverse reactions,"Diarrhea, Hypertension, Fatigue, Decreased appetite, Nausea, Dysphonia, Palmar-plantar erythrodysesthesia syndrome, Weight decreased, Vomiting, Asthenia, Constipation, Hypothyroidism, Cough, Mucosal inflammation, Arthralgia, Stomatitis, Dyspnea, Abdominal pain, Headache, Pain in extremity, Rash, Proteinuria, Dysgeusia, Dry skin, Dyspepsia, Pruritus, Alopecia, Erythema, Dizziness, Upper abdominal pain, Myalgia, Dehydration, Epistaxis, Anemia, Hemorrhoids, Hematuria, Tinnitus, Lipase increased, Glossodynia, Pulmonary embolism, Rectal hemorrhage, Hemoptysis, Deep vein thrombosis, Retinal-vein occlusion/thrombosis, Polycythemia, Transient ischemic attack, Hemoglobin decreased, Lymphocytes (absolute) decreased, Platelets decreased, White blood cells decreased, Creatinine increased, Bicarbonate decreased, Hypocalcemia, ALP increased, Hyperglycemia, Lipase increased, Amylase increased, ALT increased, AST increased, Hypernatremia, Hypoalbuminemia, Hyperkalemia, Hypoglycemia, Hyponatremia, Hypophosphatemia, Hemoglobin increased, Hypercalcemia, Death"
103,INLYTA,warnings and precautions,"Hypertension, hypertensive crisis, Arterial thrombotic events, arterial thromboembolic events, cerebrovascular accident, transient ischemic attack, myocardial infarction, retinal artery occlusion, fatal event: death, Venous thromboembolic events, pulmonary embolism, deep vein thrombosis, retinal vein occlusion, retinal vein thrombosis, fatal event: death, Hemorrhagic events, hemorrhage, cerebral hemorrhage, hematuria, hemoptysis, lower gastrointestinal hemorrhage, melena, gastric hemorrhage, fatal event: death, Cardiac failure, fatal event: death, Gastrointestinal perforation, fistula formation, fatal event: death, Hypothyroidism, hyperthyroidism, Reversible Posterior Leukoencephalopathy Syndrome (RPLS), Proteinuria, Elevation of liver enzymes, alanine aminotransferase (ALT) elevations, aspartate aminotransferase (AST) elevations, bilirubin elevation, Hepatic impairment, Pregnancy"
104,NORTHERA,adverse reactions,"Supine Hypertension, Hyperpyrexia, Confusion, Ischemic Heart Disease exacerbation, Arrhythmias exacerbation, Congestive Heart Failure exacerbation, Headache, Dizziness, Nausea, Hypertension, Fatigue, Death"
105,NORTHERA,boxed warnings,"Supine hypertension, death"
106,NORTHERA,warnings and precautions,"Supine hypertension, cardiovascular events, hyperpyrexia, confusion, neuroleptic malignant syndrome (NMS), fever, hyperthermia, muscle rigidity, involuntary movements, altered consciousness, mental status changes, ischemic heart disease exacerbation, arrhythmias exacerbation, congestive heart failure exacerbation, allergic reactions, bronchial asthma, death"
107,JARDIANCE,adverse reactions,"Hypotension, death, Impairment in Renal Function, Hypoglycemia, death, Genital Mycotic Infections, Urinary Tract Infections, Increased Low-Density Lipoprotein Cholesterol (LDL-C), Urinary tract infection, Female genital mycotic infections, Upper respiratory tract infection, Increased urination, Dyslipidemia, Arthralgia, Male genital mycotic infections, Nausea, Volume Depletion, Increased Urination, Impairment in Renal Function, Hypoglycemia, Genital Mycotic Infections, Urinary Tract Infections, Increase in Low-Density Lipoprotein Cholesterol (LDL-C), Increase in Hematocrit."
108,JARDIANCE,warnings and precautions,"Hypotension, death, Impairment in renal function, Hypoglycemia, Genital mycotic infections, Urinary tract infections, Increased LDL-C"
109,FANAPT,adverse reactions,"dizziness, dry mouth, fatigue, nasal congestion, orthostatic hypotension, somnolence, tachycardia, weight increased, death"
110,FANAPT,boxed warnings,"Death, Increased mortality, Risk of death, Cardiovascular events (e.g., heart failure, sudden death), Infectious events (e.g., pneumonia)"
111,FANAPT,warnings and precautions,"Death, cerebrovascular-related adverse events, stroke, QT prolongation, arrhythmia, sudden death, Neuroleptic Malignant Syndrome, Tardive dyskinesia, Hyperglycemia, diabetes mellitus, Dyslipidemia, Weight gain, Seizures, Orthostatic hypotension, dizziness, syncope, Leukopenia, Neutropenia, Agranulocytosis, fatal cases, Hyperprolactinemia, Body temperature regulation disruption, Dysphagia, Suicide attempt, Priapism, Cognitive and motor impairment."
112,TANZEUM,adverse reactions,"Thyroid C-cell Tumors, Acute Pancreatitis, Hypoglycemia, Insulin Secretagogues, Insulin, Hypersensitivity Reactions, Renal Impairment, death, Upper respiratory tract infection, Diarrhea, Nausea, Injection site reaction, Cough, Back pain, Arthralgia, Sinusitis, Influenza, vomiting, gastroesophageal reflux disease, dyspepsia, Constipation, injection site hematoma, injection site erythema, injection site rash, injection site hypersensitivity, injection site hemorrhage, injection site pruritus, pneumonia, Atrial Fibrillation, Atrial Flutter, Appendicitis, alanine aminotransferase (ALT) increase, Gamma Glutamyltransferase (GGT) Increase, Heart Rate Increase"
113,TANZEUM,boxed warnings,"Thyroid C-cell tumors, medullary thyroid carcinoma, MTC, mass in the neck, dysphagia, dyspnea, persistent hoarseness"
114,TANZEUM,warnings and precautions,"Thyroid C-cell Tumors, Pancreatitis, Hypoglycemia, Hypersensitivity Reactions, Renal Impairment, death"
115,EYLEA,adverse reactions,"Endophthalmitis, retinal detachments, increased intraocular pressure, thromboembolic events, conjunctival hemorrhage, eye pain, cataract, vitreous floaters, vitreous detachment, ocular hyperemia, corneal epithelium defect, detachment of the retinal pigment epithelium, injection site pain, foreign body sensation in eyes, lacrimation increased, vision blurred, intraocular inflammation, retinal pigment epithelium tear, injection site hemorrhage, eyelid edema, corneal edema, hypersensitivity, retinal tear, death."
116,EYLEA,warnings and precautions,"Endophthalmitis, Retinal detachments, Increases in intraocular pressure, Arterial thromboembolic events, Nonfatal stroke, Nonfatal myocardial infarction, Vascular death, Death"
117,JEVTANA,adverse reactions,"Bone Marrow Suppression, Hypersensitivity Reactions, Gastrointestinal Adverse Reactions, Renal Failure, Death, Neutropenia, Anemia, Leukopenia, Thrombocytopenia, Diarrhea, Fatigue, Nausea, Vomiting, Constipation, Asthenia, Abdominal Pain, Hematuria, Back Pain, Anorexia, Peripheral Neuropathy, Pyrexia, Dyspnea, Dysgeusia, Cough, Arthralgia, Alopecia, Infections, Infections (fatal), Renal Failure (fatal), Ventricular Fibrillation (fatal), Cerebral Hemorrhage (fatal), Dyspnea (fatal), Sepsis, Septic Shock, Febrile Neutropenia, Arrhythmia, Urinary Tract Infection, Weight Decreased, Dehydration, Muscle Spasms, Dizziness, Headache, Dysuria, Mucosal Inflammation, Pain, Peripheral Edema, Hypotension, Gastritis, Intestinal Obstruction."
118,JEVTANA,boxed warnings,"Neutropenia, Hypersensitivity, Generalized rash, Erythema, Hypotension, Bronchospasm, Death"
119,JEVTANA,warnings and precautions,"Bone marrow suppression, neutropenia, anemia, thrombocytopenia, pancytopenia, febrile neutropenia, neutropenic infections, sepsis, septic shock, infectious adverse events, neutropenic deaths, fatal infectious adverse events, grade 4 neutropenia, grade 3-4 neutropenia, Hypersensitivity reactions, severe hypersensitivity reactions, generalized rash/erythema, hypotension, bronchospasm, Gastrointestinal disorders, nausea, vomiting, diarrhea, mortality related to diarrhea, gastrointestinal hemorrhage, perforation, neutropenic enterocolitis, death, Renal failure, fatal outcomes, sepsis, dehydration, obstructive uropathy, Elderly patients, fatal outcomes not related to disease progression, certain adverse reactions, neutropenia, febrile neutropenia, Hepatic impairment, severe hepatic impairment, mild hepatic impairment, moderate hepatic impairment, Embryo-fetal toxicity, fetal harm."
120,YERVOY,adverse reactions,"Immune-mediated enterocolitis, colitis, Immune-mediated hepatitis, hepatotoxicity, Immune-mediated dermatitis, rash, Immune-mediated neuropathies, neuropathy, Immune-mediated endocrinopathies, endocrinopathy, Other immune-mediated adverse reactions, including ocular manifestations, Fatigue, Diarrhea, Pruritus, Rash, Colitis, Death (for severe to fatal immune-mediated adverse reactions)"
121,YERVOY,boxed warnings,"Enterocolitis, Hepatitis, Dermatitis (including toxic epidermal necrolysis), Neuropathy, Endocrinopathy, Death"
122,YERVOY,warnings and precautions,"Immune-mediated enterocolitis, diarrhea, fever, ileus, peritoneal signs, intestinal perforation, death, immune-mediated hepatitis, hepatotoxicity, hepatic failure, hospitalization, death, immune-mediated dermatitis, Stevens-Johnson syndrome, toxic epidermal necrolysis, rash, dermal ulceration, necrotic manifestations, bullous manifestations, hemorrhagic manifestations, death, immune-mediated neuropathies, Guillain-Barre syndrome, peripheral motor neuropathy, myasthenia gravis, death, immune-mediated endocrinopathies, hypopituitarism, adrenal insufficiency, hypogonadism, hypothyroidism, hyperthyroidism, Cushing's syndrome, hospitalization, death, other immune-mediated adverse reactions, nephritis, pneumonitis, meningitis, pericarditis, uveitis, iritis, hemolytic anemia, myocarditis, angiopathy, temporal arteritis, vasculitis, polymyalgia rheumatica, conjunctivitis, blepharitis, episcleritis, scleritis, leukocytoclastic vasculitis, erythema multiforme, psoriasis, pancreatitis, arthritis, autoimmune thyroiditis, sarcoidosis, neurosensory hypoacusis, autoimmune central neuropathy, myositis, polymyositis, ocular myositis, death."
123,FARXIGA,adverse reactions,"Hypotension, death, Impairment in Renal Function, Hypoglycemia, death, Genital Mycotic Infections, Increases in Low-Density Lipoprotein Cholesterol (LDL-C), Bladder Cancer, Female genital mycotic infections, vulvovaginal mycotic infection, vaginal infection, vulvovaginal candidiasis, vulvovaginitis, genital infection, genital candidiasis, fungal genital infection, vulvitis, genitourinary tract infection, vulval abscess, vaginitis bacterial, Nasopharyngitis, Urinary tract infections, urinary tract infection, cystitis, Escherichia urinary tract infection, genitourinary tract infection, pyelonephritis, trigonitis, urethritis, kidney infection, prostatitis, Back pain, Increased urination, pollakiuria, polyuria, urine output increased, Male genital mycotic infections, balanitis, fungal genital infection, balanitis candida, genital candidiasis, genital infection male, penile infection, balanoposthitis, balanoposthitis infective, posthitis, Nausea, Influenza, Dyslipidemia, Constipation, Discomfort with urination, Pain in extremity, Volume Depletion, dehydration, hypovolemia, orthostatic hypotension, Renal failure, blood creatinine increase, Bone fractures, Hypersensitivity reactions, angioedema, urticaria, hypersensitivity, Increase in Hematocrit, Increase in Serum Inorganic Phosphorus, Increase in Low-Density Lipoprotein Cholesterol."
124,FARXIGA,warnings and precautions,"Hypotension, Impairment in renal function, Hypoglycemia, Genital mycotic infections, Increases in Low-Density Lipoprotein Cholesterol (LDL-C), Bladder Cancer, Death"
125,PICATO,adverse reactions,"local skin reactions, erythema, flaking/scaling, crusting, swelling, vesiculation/pustulation, erosion/ulceration, application site pain, application site pruritus, application site irritation, application site infection, periorbital edema, nasopharyngitis, headache, eyelid edema, eye pain, conjunctivitis"
126,PICATO,warnings and precautions,"severe eye pain, chemical conjunctivitis, corneal burn, eyelid edema, eyelid ptosis, periorbital edema, vesiculation/pustulation, erosion/ulceration, anaphylaxis, allergic contact dermatitis, erythema, crusting, swelling, vesiculation/postulation, erosion/ulceration, death"
127,PRISTIQ,adverse reactions,"Hypersensitivity, Suicidal Thoughts, Serotonin Syndrome, Elevated Blood Pressure, Abnormal Bleeding, Angle Closure Glaucoma, Activation of Mania/Hypomania, Discontinuation Syndrome, Seizure, Hyponatremia, Interstitial Lung Disease, Eosinophilic Pneumonia, death, nausea, dizziness, insomnia, hyperhidrosis, constipation, somnolence, decreased appetite, anxiety, specific male sexual function disorders, headache, vomiting, fatigue, chills, feeling jittery, tremor, disturbance in attention, abnormal dreams, urinary hesitation, vision blurred, mydriasis, vertigo, tinnitus, dysgeusia, hot flush, anorgasmia, libido decreased, orgasm abnormal, ejaculation delayed, erectile dysfunction, ejaculation disorder, ejaculation failure, sexual dysfunction, asthenia, weight increased, liver function test abnormal, blood prolactin increased, musculoskeletal stiffness, syncope, convulsion, dystonia, depersonalization, bruxism, urinary retention, rash, alopecia, photosensitivity reaction, angioedema, tachycardia, myocardial ischemia, myocardial infarction, coronary occlusion, proteinuria, orthostatic hypotension, Stevens-Johnson syndrome."
128,PRISTIQ,boxed warnings,"suicidal thoughts, suicidal behaviors, risk of suicidal thinking, risk of suicidal behavior, worsening, emergence of suicidal thoughts, emergence of suicidal behaviors, death"
129,PRISTIQ,warnings and precautions,"suicidal thoughts, suicide, serotonin syndrome, elevated blood pressure, abnormal bleeding, angle closure glaucoma, activation of mania/hypomania, discontinuation syndrome, seizure, hyponatremia, interstitial lung disease, eosinophilic pneumonia, death"
130,STRIBILD,adverse reactions,"Lactic Acidosis, Severe Hepatomegaly with Steatosis, Severe Acute Exacerbations of Hepatitis B, New Onset or Worsening Renal Impairment, Bone Effects of Tenofovir DF, Immune Reconstitution Syndrome, nausea, diarrhea, Ocular icterus, Diarrhea, Flatulence, Nausea, Fatigue, Jaundice, Somnolence, Headache, Dizziness, Insomnia, Abnormal dreams, Rash, suicidal ideation, suicide attempt, depression, abdominal pain, dyspepsia, vomiting, fever, pain, nasopharyngitis, pneumonia, sinusitis, upper respiratory tract infection, arthralgia, back pain, myalgia, paresthesia, peripheral neuropathy, anxiety, increased cough, rhinitis, skin discoloration, hyperpigmentation, laboratory abnormalities, AST elevation, ALT elevation, Amylase elevation, Creatine Kinase elevation, Hematuria, Bone Mineral Density (BMD) decrease, bone fractures, proteinuria, serum creatinine increase, estimated creatinine clearance decrease, ALT elevation, alkaline phosphatase elevation, bilirubin elevation, serum glucose abnormality, glycosuria, neutrophil count decrease, fasting cholesterol abnormality, fasting triglycerides abnormality, lipid values change, total cholesterol increase, HDL-cholesterol increase, LDL-cholesterol increase, triglycerides increase, allergic reaction, angioedema, lactic acidosis, hypokalemia, hypophosphatemia, dyspnea, pancreatitis, increased amylase, abdominal pain, hepatic steatosis, hepatitis, increased liver enzymes, rash, rhabdomyolysis, osteomalacia, bone pain, fractures, muscular weakness, myopathy, acute renal failure, renal failure, acute tubular necrosis, Fanconi syndrome, proximal renal tubulopathy, interstitial nephritis, nephrogenic diabetes insipidus, renal insufficiency, increased creatinine, proteinuria, polyuria, asthenia."
131,STRIBILD,boxed warnings,"Lactic acidosis, Severe hepatomegaly with steatosis, Death, Acute exacerbation of hepatitis B"
132,STRIBILD,warnings and precautions,"Lactic acidosis, severe hepatomegaly with steatosis, renal impairment, acute renal failure, Fanconi syndrome, bone mineral density decreases, redistribution/accumulation of body fat, immune reconstitution syndrome, death."
133,NULOJIX,adverse reactions,"Post-Transplant Lymphoproliferative Disorder (PTLD), CNS PTLD, Non-CNS PTLD, death, Progressive Multifocal Leukoencephalopathy (PML), death, Bacterial, Mycobacterial, Viral, and Fungal Infections, Cryptococcal meningitis, Infusion Reactions, Proteinuria, New-Onset Diabetes After Transplantation (NODAT), Hypertension, Dyslipidemia, Guillain-Barre syndrome, Stomatitis, including aphthous stomatitis, Chronic allograft nephropathy, Complications of transplanted kidney, including wound dehiscence, arteriovenous fistula thrombosis, Neutropenia, Renal impairment, including acute renal failure, renal artery stenosis, urinary incontinence, hydronephrosis, Hematoma, Lymphocele, Musculoskeletal pain, Alopecia, Hyperhidrosis, Atrial fibrillation"
134,NULOJIX,boxed warnings,"Post-transplant lymphoproliferative disorder (PTLD), other malignancies, serious infections, increased risk for developing PTLD, increased risk for developing malignancies, increased susceptibility to infection, possible development of malignancies, increased risk of graft loss, death."
135,NULOJIX,warnings and precautions,"Post-Transplant Lymphoproliferative Disorder, PTLD, CNS, neurological, cognitive, behavioral signs and symptoms, malignancies, immunosuppressants, UV light, sunlight, Progressive Multifocal Leukoencephalopathy, PML, bacterial infections, viral infections, fungal infections, protozoal infections, opportunistic infections, tuberculosis, Polyoma virus-associated nephropathy, kidney graft loss, cytomegalovirus, pneumocystis, liver transplant, Acute Rejection, Graft Loss, Corticosteroid Minimization, immunizations, live vaccines, death"
136,LUMIZYME,adverse reactions,"Hypersensitivity reactions, anaphylaxis, rash, pyrexia, flushing/feeling hot, urticaria, headache, hyperhidrosis, nausea, cough, decreased oxygen saturation, tachycardia, tachypnea, chest discomfort, dizziness, muscle twitching, agitation, cyanosis, erythema, hypertension/increased blood pressure, pallor, rigors, tremor, vomiting, fatigue, myalgia, death, livedo reticularis, irritability, retching, increased lacrimation, ventricular extrasystoles, nodal rhythm, rales, respiratory tract irritation, cold sweat, angioedema, throat tightness, chest pain/discomfort, supraventricular tachycardia, paresthesia, local swelling, diarrhea, pruritus, rash papular, edema, peripheral, throat tightness, delayed-onset reactions, hyperparathyroidism, respiratory failure, respiratory arrest, cardiac arrest, hypoxia, dyspnea, wheezing, convulsions, peripheral coldness, restlessness, nervousness, back pain, stridor, pharyngeal edema, abdominal pain, apnea, muscle spasm, conjunctivitis, proteinuria, nephrotic syndrome, membranous glomerulonephritis, necrotizing skin lesions."
137,LUMIZYME,boxed warnings,"Anaphylaxis, hypersensitivity, immune-mediated reactions, respiratory distress, hypoxia, apnea, dyspnea, bradycardia, tachycardia, bronchospasm, throat tightness, hypotension, angioedema, tongue swelling, lip swelling, periorbital edema, face edema, urticaria, proteinuria, nephrotic syndrome, necrotizing skin lesions, death."
138,LUMIZYME,warnings and precautions,"Anaphylaxis, Hypersensitivity Reactions, death, Immune-Mediated Reactions, Acute Cardiorespiratory Failure, Cardiac Arrhythmia, Sudden Cardiac Death, Antibody Development"
139,EOVIST,adverse reactions,"Nephrogenic systemic fibrosis, death, hypersensitivity reactions, anaphylactic shock, hypotension, pharyngolaryngeal edema, urticaria, face edema, rhinitis, conjunctivitis, abdominal pain, hypoesthesia, sneezing, cough, pallor, tachycardia, restlessness, nausea, headache, feeling hot, dizziness, back pain, vomiting, blood pressure increased, injection site reactions (pain, burning, coldness, extravasation, irritation), dysgeusia, paresthesia, flushing, parosmia, pruritus (generalized, eye), rash, respiratory disorders (dyspnea, respiratory distress), fatigue, chest pain, vertigo, dry mouth, chills, feeling abnormal, tremor, akathisia, bundle branch block, palpitation, oral discomfort, salivary hypersecretion, maculopapular rash, hyperhidrosis, discomfort, malaise."
140,EOVIST,boxed warnings,"Nephrogenic systemic fibrosis (NSF), Fatal or debilitating fibrosis affecting the skin, muscle, and internal organs, Death."
141,EOVIST,warnings and precautions,"Nephrogenic Systemic Fibrosis, NSF, Hypersensitivity, Anaphylactoid reactions, Cardiovascular reactions, Respiratory reactions, Cutaneous reactions, Shock, Acute Kidney Injury, Extravasation, Injection Site Reactions, Interference with Laboratory Tests, Interference with Visualization of Liver Lesions"
142,BELEODAQ,adverse reactions,"Hematologic Toxicity, Infection, Hepatotoxicity, Tumor Lysis Syndrome, Gastrointestinal Toxicity, nausea, fatigue, pyrexia, anemia, vomiting, constipation, diarrhea, dyspnea, rash, peripheral edema, cough, thrombocytopenia, pruritus, chills, increased blood lactate dehydrogenase, decreased appetite, headache, infusion site pain, hypokalemia, prolonged QT, abdominal pain, hypotension, phlebitis, dizziness, pneumonia, increased creatinine, multi-organ failure, tumor lysis syndrome, death, hepatic failure, ventricular fibrillation, febrile neutropenia."
143,BELEODAQ,warnings and precautions,"Thrombocytopenia, leukopenia, neutropenia, lymphopenia, anemia, infection, death, hepatotoxicity, tumor lysis syndrome, embryo-fetal toxicity."
144,VICTRELIS,adverse reactions,"Fatigue, Anemia, Nausea, Headache, Dysgeusia, Neutropenia, Pancytopenia, Hypersensitivity, Death (for fatal events), Dry mouth, Diarrhea, Vomiting, Decreased appetite, Arthralgia, Dizziness, Insomnia, Irritability, Dyspnea exertional, Alopecia, Dry skin, Rash, Chills, Asthenia, Decreased hemoglobin, Decreased neutrophils, Decreased platelets, Agranulocytosis, Thrombocytopenia, Mouth ulceration, Stomatitis, Pneumonia, Sepsis, Angioedema, Urticaria, Drug rash with eosinophilia and systemic symptoms (DRESS) syndrome, Exfoliative rash, Exfoliative dermatitis, Stevens-Johnson syndrome, Toxic skin eruption, Toxicoderma"
145,VICTRELIS,warnings and precautions,"Embryofetal Toxicity, birth defects, fetal death, anemia, hemoglobin decrease, neutropenia, worsening neutropenia, hypersensitivity, acute hypersensitivity reactions, urticaria, angioedema, death"
146,VIMIZIM,adverse reactions,"Anaphylaxis, hypersensitivity reactions, pyrexia, vomiting, headache, nausea, abdominal pain, chills, fatigue, death"
147,VIMIZIM,boxed warnings,"Anaphylaxis, cough, erythema, throat tightness, urticaria, flushing, cyanosis, hypotension, rash, dyspnea, chest discomfort, gastrointestinal symptoms, nausea, abdominal pain, retching, vomiting, death"
148,VIMIZIM,warnings and precautions,"Anaphylaxis, hypersensitivity reactions, cough, erythema, throat tightness, urticaria, flushing, cyanosis, hypotension, rash, dyspnea, chest discomfort, gastrointestinal symptoms, nausea, abdominal pain, retching, vomiting, peripheral edema, sleep apnea, airway patency, spinal cord compression, back pain, paralysis, urinary incontinence, fecal incontinence, death"
149,SIRTURO,adverse reactions,"Increased mortality, QT Prolongation, Hepatotoxicity, Drug Interactions, Nausea, Arthralgia, Headache, Hemoptysis, Chest Pain, Anorexia, Transaminases Increased, Rash, Blood Amylase Increased, Death"
150,SIRTURO,boxed warnings,"Increased Mortality, Death, QT Prolongation"
151,SIRTURO,warnings and precautions,"QT prolongation, ventricular arrhythmia, hepatotoxicity, increased mortality, death, Torsade de Pointes, congenital long QT syndrome, hypothyroidism, bradyarrhythmias, uncompensated heart failure, syncope, hepatic-related adverse reactions, fatigue, anorexia, nausea, jaundice, dark urine, liver tenderness, hepatomegaly, aminotransferase elevations, total bilirubin elevation, CYP3A4 inducers, CYP3A4 inhibitors."
152,NEURACEQ,adverse reactions,"Injection site reaction, Erythema, Irritation, Pain"
153,NEURACEQ,warnings and precautions,"Image interpretation errors, False positives, Errors in the estimation of brain neuritic beta-amyloid plaque density, Errors due to severe brain atrophy, Errors due to motion artifacts, Increased risk of cancer"
154,COMETRIQ,adverse reactions,"Perforations, Fistula, Hemorrhage, Thromboembolic Events, Wound Complications, Hypertension, Osteonecrosis of the Jaw, Palmar-plantar erythrodysesthesia syndrome, Proteinuria, Reversible Posterior Leukoencephalopathy Syndrome, diarrhea, stomatitis, palmar-plantar erythrodysesthesia syndrome, decreased weight, decreased appetite, nausea, fatigue, oral pain, hair color changes, dysgeusia, hypertension, abdominal pain, constipation, increased AST, increased ALT, lymphopenia, increased alkaline phosphatase, hypocalcemia, neutropenia, thrombocytopenia, hypophosphatemia, hyperbilirubinemia, dehydration, arthralgia, muscle spasms, musculoskeletal chest pain, dysgeusia, headache, dizziness, paresthesia, peripheral sensory neuropathy, peripheral neuropathy, anxiety, dysphonia, PPES, hair color changes/depigmentation, graying, rash, dry skin, alopecia, erythema, hyperkeratosis, hypertension, hypotension, increased AST, increased ALT, increased ALP, hypocalcemia, hypophosphatemia, hyperbilirubinemia, hypomagnesemia, hypokalemia, hyponatremia, lymphopenia, neutropenia, thrombocytopenia, hypertension. Additionally, 'death' should be added to the list due to fatal adverse reactions mentioned in the text."
155,COMETRIQ,boxed warnings,"Perforations, Fistulas, Hemorrhage, Death"
156,COMETRIQ,warnings and precautions,"Thrombotic Events, death, Wound Complications, Hypertension, Osteonecrosis of the Jaw, Palmar-plantar Erythrodysesthesia syndrome, Proteinuria, Reversible Posterior Leukoencephalopathy Syndrome, death, Gastrointestinal perforations, Fistulas, Hemorrhage, death."
157,AFINITOR,adverse reactions,"Non-infectious pneumonitis, infections, angioedema, oral ulceration, renal failure, impaired wound healing, death, stomatitis, rash, fatigue, diarrhea, edema, abdominal pain, nausea, fever, asthenia, cough, headache, decreased appetite, renal angiomyolipoma, respiratory tract infection, SEGA, hyperglycemia, dyspnea, hypercholesterolemia, lymphopenia, thrombocytopenia, leukopenia, increased aspartate transaminase (AST), anemia, increased alanine transaminase (ALT), hypertriglyceridemia, weight decreased, arthralgia, back pain, pain in extremity, dysgeusia, insomnia, dry mouth, pyrexia, mucosal inflammation, constipation, vomiting, decreased appetite, diabetes mellitus, muscle spasms, epistaxis, pruritus, alopecia, hot flush, irregular menstruation, hypertension, pleural effusion, pharyngolaryngeal pain, rhinorrhea, nail disorders, erythema, onychoclasis, skin lesion, acneiform dermatitis, angioedema, tachycardia, congestive cardiac failure, jaw pain, hemorrhage, cellulitis, hyperglycemia, elevated creatinine, acute pancreatitis, cholecystitis, cholelithiasis, arterial thrombotic events, reflex sympathetic dystrophy."
158,AFINITOR,warnings and precautions,"Non-infectious pneumonitis, death, infections, death, angioedema, oral ulceration, renal failure, death, impaired wound healing, laboratory test alterations, death, vaccinations, embryo-fetal toxicity"
159,BREO,adverse reactions,"LABA, vilanterol: increase the risk of asthma-related death, Inhaled corticosteroids: Candida albicans infection, immunosuppression, hypercorticism, adrenal suppression, reduction in bone mineral density, Systemic corticosteroid use: Candida albicans infection, increased risk of pneumonia in COPD, immunosuppression, hypercorticism, adrenal suppression, reduction in bone mineral density, Nasopharyngitis, upper respiratory tract infection, headache, oral candidiasis, influenza, bronchitis, sinusitis, oropharyngeal pain, dysphonia, cough, Back pain, pneumonia, Viral respiratory tract infection, pharyngitis, pyrexia, arthralgia, Palpitations, tachycardia, Hypersensitivity reactions: anaphylaxis, angioedema, rash, urticaria, Muscle spasms, Tremor, Nervousness, Death"
160,BREO,boxed warnings,"Asthma-related death, death, Increase in asthma-related deaths, Risk of asthma-related death, Increase in asthma-related hospitalization"
161,BREO,warnings and precautions,"asthma-related death, death, deterioration of disease, acute episodes, pneumonia, death, immunosuppression, infections, chickenpox, measles, tuberculosis, fungal infections, bacterial infections, viral infections, parasitic infections, ocular herpes simplex, adrenal insufficiency, hypercorticism, adrenal suppression, paradoxical bronchospasm, hypersensitivity reactions, anaphylaxis, cardiovascular effects, bone mineral density reduction, glaucoma, cataracts, convulsive disorders, thyrotoxicosis, diabetes mellitus, ketoacidosis, hypokalemia, hyperglycemia, growth velocity reduction"
162,FIRAZYR,adverse reactions,"Injection site reactions, death, Pyrexia, Transaminase increase, Dizziness, Rash, Nausea, Headache"
163,FIRAZYR,warnings and precautions,"Laryngeal attacks, Airway obstruction"
164,INVOKANA,adverse reactions,"Hypotension, death, Impairment in Renal Function, Hyperkalemia, Hypoglycemia, death, Genital Mycotic Infections, Hypersensitivity Reactions, Bone Fracture, Increases in Low-Density Lipoprotein (LDL-C), Female genital mycotic infections, Urinary tract infections, Increased urination, Male genital mycotic infections, Vulvovaginal pruritus, Thirst, Constipation, Nausea, Abdominal pain, Fatigue, Loss of strength or energy (asthenia), Pancreatitis (acute or chronic), Hypersensitivity-related adverse reactions, Photosensitivity-related adverse reactions, Volume Depletion-Related Adverse Reactions, Falls, Increases in Serum Potassium, Increases in Serum Magnesium, Increases in Serum Phosphate, Increases in Low-Density Lipoprotein Cholesterol (LDL-C) and non-High-Density Lipoprotein Cholesterol (non-HDL-C), Increases in Hemoglobin, Decreases in Bone Mineral Density"
165,INVOKANA,warnings and precautions,"Hypotension, Impairment in Renal Function, Hyperkalemia, Hypoglycemia, Genital mycotic infections, Hypersensitivity reactions, Bone fracture, Increased LDL-C"
166,VORAXAZE,adverse reactions,"anaphylactic reactions, paraesthesias, flushing, nausea, vomiting, hypotension, headache, myelosuppression, mucositis, acute hepatitis, renal dysfunction, renal failure, death"
167,VORAXAZE,warnings and precautions,"Serious allergic reactions, anaphylactic reactions, death, interference with assay"
168,NESINA,adverse reactions,"Nasopharyngitis, Headache, Upper Respiratory Tract Infection, Pancreatitis, Hypersensitivity Reactions (including anaphylaxis, angioedema, rash, urticaria, and severe cutaneous adverse reactions such as Stevens-Johnson syndrome), Hypoglycemia, Death (if a fatal event is listed)"
169,NESINA,warnings and precautions,"Acute pancreatitis, Hypersensitivity, Anaphylaxis, Angioedema, Severe cutaneous adverse reactions, Hepatic failure, Death, Hypoglycemia, Arthralgia"
170,GILENYA,adverse reactions,"Bradyarrhythmia, Atrioventricular Blocks, Infections, Progressive multifocal leukoencephalopathy, Macular Edema, Posterior Reversible Encephalopathy Syndrome, Respiratory Effects, Liver Injury, Headache, liver transaminase elevation, diarrhea, cough, influenza, sinusitis, back pain, abdominal pain, pain in extremity, serum transaminase elevations, basal cell carcinoma, Influenza, Sinusitis, Bronchitis, Herpes zoster, Tinea versicolor, Bradycardia, Migraine, Nausea, Asthenia, Alopecia, Actinic keratosis, Blood triglycerides increased, Dyspnea, Vision blurred, Hypertension, Lymphopenia, Leukopenia, Skin papilloma, Basal cell carcinoma, dizziness, pneumonia, eczema, pruritus, Vascular Events, ischemic strokes, hemorrhagic strokes, peripheral arterial occlusive disease, Lymphomas, death"
171,GILENYA,warnings and precautions,"Bradycardia, atrioventricular conduction, bradyarrhythmia, atrioventricular blocks, Infections, Progressive multifocal leukoencephalopathy (PML), Macular edema, Posterior reversible encephalopathy syndrome (PRES), Decrease in pulmonary function tests (PFT), respiratory effects, Liver injury, Fetal risk, Blood pressure effects, Herpes zoster, herpes simplex encephalitis, disseminated varicella zoster, multiorgan failure, Progressive multifocal leukoencephalopathy (PML), Posterior reversible encephalopathy syndrome (PRES)"
172,HALAVEN,adverse reactions,"Neutropenia, anemia, asthenia/fatigue, alopecia, peripheral neuropathy, nausea, constipation, death, febrile neutropenia, headache, mucosal inflammation, pyrexia, diarrhea, vomiting, arthralgia/myalgia, back pain, bone pain, pain in extremity, weight decreased, anorexia, cough, dyspnea, urinary tract infection, alopecia, increased lacrimation, dyspepsia, abdominal pain, stomatitis, dry mouth, peripheral edema, upper respiratory tract infection, hypokalemia, muscle spasms, muscular weakness, dysgeusia, dizziness, insomnia, depression, rash, lymphopenia, pancreatitis, hepatotoxicity, drug hypersensitivity, pneumonia, sepsis/neutropenic sepsis, hypomagnesemia, dehydration, interstitial lung disease, pruritus."
173,HALAVEN,warnings and precautions,"Neutropenia, Peripheral Neuropathy, Embryo-Fetal Toxicity, QT Prolongation"
174,INTELENCE,adverse reactions,"Severe skin reactions, hypersensitivity reactions, rash, peripheral neuropathy, diarrhea, Stevens-Johnson syndrome, drug hypersensitivity reaction, erythema multiforme, death (fatal cases of toxic epidermal necrolysis)"
175,INTELENCE,warnings and precautions,"Severe skin reactions, Potentially life-threatening skin reactions, Fatal skin reactions, Stevens-Johnson syndrome, Hypersensitivity reaction, Toxic epidermal necrolysis, Erythema multiforme, Drug Rash with Eosinophilia and Systemic Symptoms (DRESS), Rash with systemic symptoms, Liver transaminase elevations, Hepatic failure, Rash, Constitutional findings, Organ dysfunction, Grade 3 and 4 rashes, Central obesity, Dorsocervical fat enlargement (buffalo hump), Peripheral wasting, Facial wasting, Breast enlargement, ""Cushingoid appearance"", Immune reconstitution syndrome, Inflammatory response to opportunistic infections, Autoimmune disorders, Graves' disease, Polymyositis, Guillain-Barre syndrome, Death."
176,AMYVID,adverse reactions,"Headache, death, Musculoskeletal pain, Blood pressure increased, hypertension, Nausea, Fatigue, Injection site reaction, injection site haemorrhage, injection site irritation, injection site pain, Anxiety, Back pain, Claustrophobia, Dizziness, Feeling cold, chills, Insomnia, Neck pain, Infusion site rash, Dysgeusia, Pruritis, Urticaria, Flushing"
177,AMYVID,warnings and precautions,"Image interpretation errors, False negatives, Radiation risk, Radiation exposure, Errors in Amyvid estimation, Brain neuritic plaque density errors, Errors due to brain atrophy, Errors due to motion artifacts, Increased risk of cancer"
178,ULESFIA,adverse reactions,"Ocular irritation, Application site irritation, Application site anesthesia, Hypoesthesia, Pain, Pruritus, Erythema, Pyoderma, Dryness, Excoriation, Paraesthesia, Dermatitis, Thermal burn, Dandruff, Rash, Skin exfoliation"
179,ULESFIA,warnings and precautions,"Neonatal toxicity, gasping syndrome, severe metabolic acidosis, gasping respirations, progressive hypotension, seizures, central nervous system depression, intraventricular hemorrhage, death, Eye irritation, Contact dermatitis."
180,OTEZLA,adverse reactions,"Diarrhea, nausea, headache, upper respiratory tract infection, tension headache, vomiting, nasopharyngitis, abdominal pain upper, weight decrease, frequent bowel movement, gastroesophageal reflux disease, dyspepsia, decreased appetite, migraine, cough, rash, fatigue, insomnia, back pain, depression, bronchitis, tooth abscess, folliculitis, sinus headache, death"
181,OTEZLA,warnings and precautions,"Depression, suicidal thoughts, mood changes, instances of suicidal ideation and behavior, attempted suicide, suicide, weight decrease, weight loss, death"
182,ILARIS,adverse reactions,"nasopharyngitis, diarrhea, influenza, headache, nausea, abdominal pain, injection site reactions, vertigo, infections, rhinitis, bronchitis, gastroenteritis, pharyngitis, weight increased, musculoskeletal pain, bronchitis, hypersensitivity, pneumonia, varicella, measles, sepsis, otitis media, sinusitis, adenovirus, lymph node abscess, death"
183,ILARIS,warnings and precautions,"Serious infections, upper respiratory tract infections, aspergillosis, atypical mycobacterial infections, cytomegalovirus, herpes zoster, tuberculosis, opportunistic infections, reactivation of latent tuberculosis, immune system infections, new tuberculosis, latent tuberculosis infection, signs of tuberculosis, hypersensitivity reactions, anaphylactic reactions, clinical hypersensitivity, immunosuppression, malignancies, hypersensitivity, immunizations, live vaccines, secondary transmission of infection, normal immune response, pneumococcal vaccine, inactivated influenza vaccine, Macrophage Activation Syndrome, life-threatening disorder, SJIA, symptoms of infection, worsening of SJIA, triggers for MAS, MAS, death."
184,NATAZIA,adverse reactions,"Serious cardiovascular events, stroke, death, vascular events, liver disease, irregular uterine bleeding, nausea, breast tenderness, headache, death, headaches, migraines, breast pain, breast discomfort, breast tenderness, breast tenderness, pain, menstrual disorders, vomiting, acne, mood changes, increased weight, myocardial infarction, ruptured ovarian cyst, deep vein thrombosis, focal nodular hyperplasia of the liver, uterine leiomyoma, acute cholecystitis, chronic acalculous cholecystitis, venous thromboembolic events, arterial thromboembolic events, pulmonary emboli, cerebral thrombosis, hypertension, gallbladder disease, hepatitis, hypersensitivity, fluid retention, hypertriglyceridemia, dizziness, chloasma, angioedema, erythema nodosum, erythema multiforme, gastrointestinal symptoms, abdominal pain, vulvovaginal candidiasis."
185,NATAZIA,boxed warnings,"Serious cardiovascular events, Cardiovascular events, death"
186,NATAZIA,warnings and precautions,"Thrombotic event, Vascular risks, Thromboembolic Disorders, Vascular Problems, Venous thromboembolism, Arterial thrombotic event, VTE, Venous thromboembolism, Arterial thromboses, Strokes, Myocardial infarctions, Cerebrovascular events, Thrombotic strokes, Hemorrhagic strokes, Arterial thromboses, Thromboembolic disease, Thromboembolism, Thromboembolic event, Thromboembolism, Thromboembolic disease, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thromboembolism, Thrombo"
187,DIFICID,adverse reactions,"nausea, vomiting, abdominal pain, gastrointestinal hemorrhage, anemia, neutropenia, death, dyspnea, angioedema, rash, pruritus"
188,DIFICID,warnings and precautions,"Acute hypersensitivity reactions, Angioedema, Dyspnea, Pruritus, Rash, Death"
189,ONFI,adverse reactions,"Somnolence, Sedation, Potentiation of Sedation, Withdrawal Symptoms, Serious Dermatological Reactions, Physical and Psychological Dependence, Suicidal Behavior, Ideation, Constipation, Pyrexia, Lethargy, Drooling, Death"
190,ONFI,warnings and precautions,"Somnolence, Sedation, Central nervous system (CNS) depression, Withdrawal symptoms, Serious dermatological reactions, Stevens-Johnson syndrome, Toxic epidermal necrolysis, Physical dependence, Psychological dependence, Substance abuse, Suicidal behavior, Suicidal ideation"
191,TECFIDERA,adverse reactions,"Anaphylaxis, Angioedema, Progressive multifocal leukoencephalopathy, Lymphopenia, Flushing, abdominal pain, diarrhea, nausea, vomiting, pruritus, rash, albumin urine present, erythema, dyspepsia, aspartate aminotransferase increased, GI events, hepatic transaminases, eosinophilia, death"
192,TECFIDERA,warnings and precautions,"Anaphylaxis, angioedema, death, Progressive Multifocal Leukoencephalopathy, PML, lymphopenia, Flushing"
193,DYSPORT,adverse reactions,"Distant Spread of Toxin Effect, Lack of Interchangeability between Botulinum Toxin Products, Spread of Effects from Toxin, Dysphagia, Breathing Difficulties, Facial Anatomy in the Treatment of Glabellar Lines, Pre-existing Neuromuscular Disorders, Human Albumin, Intradermal Immune Reaction, muscular weakness, dry mouth, injection site discomfort, fatigue, headache, neck pain, musculoskeletal pain, dysphonia, injection site pain, eye disorders, nasopharyngitis, upper respiratory tract infection, eyelid edema, eyelid ptosis, sinusitis, nausea, urinary tract infection, dizziness, fall, depression, disturbance in attention, feeling abnormal, muscle atrophy, dyspnea, bronchitis, influenza, pharyngolaryngeal pain, cough, contact dermatitis, injection site swelling, blood present in urine, convulsion, syncope, hypoaesthesia, partial seizures, asthenia, injury, contusion, diarrhea, constipation, blood triglycerides increased, hypertension, vertigo, photophobia, influenza-like illness, amyotrophy, burning sensation, hypoesthesia, erythema, excessive granulation tissue, gait disturbance, hypertonia, sensation of heaviness, antibody formation, binding antibodies, neutralizing antibodies."
194,DYSPORT,boxed warnings,"asthenia, generalized muscle weakness, diplopia, blurred vision, ptosis, dysphagia, dysphonia, dysarthria, urinary incontinence, breathing difficulties, death"
195,DYSPORT,warnings and precautions,"Dysphagia, Swallowing difficulties, Breathing difficulties, Respiratory disorders, Speech difficulties, Asthenia, Generalized muscle weakness, Diplopia, Blurred vision, Ptosis, Dysphonia, Dysarthria, Urinary incontinence, Death"
196,ZYTIGA,adverse reactions,"Hypertension, Hypokalemia, Fluid Retention, Adrenocortical Insufficiency, Hepatotoxicity, fatigue, joint swelling, discomfort, edema, hot flush, diarrhea, vomiting, cough, dyspnea, urinary tract infection, contusion, anemia, elevated alkaline phosphatase, hypertriglyceridemia, lymphopenia, hypercholesterolemia, hyperglycemia, elevated AST, hypophosphatemia, elevated ALT, myopathy, rhabdomyolysis, arrhythmia, chest pain, chest discomfort, cardiac failure, cardiorespiratory arrest, myocardial ischemia, myocardial infarction, death."
197,ZYTIGA,warnings and precautions,"hypertension, hypokalemia, fluid retention, edema, adrenocortical insufficiency, hepatotoxicity, death"
198,DUAVEE,adverse reactions,"Cardiovascular Disorders, Malignant Neoplasms, Gallbladder Disease, Hypertriglyceridemia, muscle spasms, nausea, diarrhea, dyspepsia, abdominal pain upper, oropharyngeal pain, dizziness, neck pain, death, hot flush."
199,DUAVEE,boxed warnings,"endometrial cancer, cardiovascular disorders, probable dementia, stroke, deep vein thrombosis, dementia, blood clots, heart attack, cancer of the lining of the uterus, breast cancer, cancer of the ovary, gallbladder problems, loss of vision, high blood pressure, increased fats in your blood, liver problems, thyroid problems, fluid retention, low calcium, swelling of your mouth or tongue, worsening of other medical problems such as asthma, diabetes, epilepsy, migraines, a genetic problem called porphyria, lupus and liver problems, death"
200,DUAVEE,warnings and precautions,"Venous thromboembolism, Pulmonary embolism, Stroke, Retinal vascular thrombosis, Endometrial cancer, Breast cancer, Ovarian cancer, Gallbladder disease, Loss of vision, Severe hypertriglyceridemia, Cholestatic jaundice, Thyroid dysfunction, Visual abnormalities, Elevated blood pressure, Hypertriglyceridemia, Hepatic impairment, Cholestatic jaundice, Hypothyroidism, Fluid retention, Hypocalcemia, Hereditary angioedema, Exacerbation of asthma, Exacerbation of diabetes mellitus, Exacerbation of epilepsy, Exacerbation of migraine, Exacerbation of porphyria, Exacerbation of systemic lupus erythematosus, Exacerbation of hepatic hemangiomas, Accelerated prothrombin time, Partial thromboplastin time, Platelet aggregation time, Increased platelet count, Increased factors II, VII antigen, VIII antigen, VIII coagulant activity, IX, X, XII, VII-X complex, II-VII-X complex, and beta-thromboglobulin, Decreased levels of antifactor Xa and antithrombin III, Decreased antithrombin III activity, Increased levels of fibrinogen and fibrinogen activity, Increased plasminogen antigen and activity, Increased thyroid-binding globulin (TBG), Increased circulating total thyroid hormone, Increased levels of plasma high-density lipoprotein (HDL) and HDL2 cholesterol subfraction concentrations, Reduced low-density lipoprotein (LDL) cholesterol concentrations, Increased triglyceride levels, Impaired glucose tolerance, Death"
201,SAPHRIS,adverse reactions,"Neuroleptic Malignant Syndrome, NMS, Tardive Dyskinesia, Metabolic Changes, Hypersensitivity Reactions, Application site reactions, including oral ulcers, blisters, peeling/sloughing, and inflammation, Orthostatic Hypotension, Syncope, Hemodynamic Effects, Leukopenia, Neutropenia, Agranulocytosis, QT Interval Prolongation, Hyperprolactinemia, Seizures, Cognitive Impairment, Motor Impairment, Body Temperature Regulation, Suicide, Dysphagia, Akathisia, Oral Hypoesthesia, Somnolence, Dizziness, Extrapyramidal Symptoms, Increased Weight, Dysgeusia, Oral Paresthesia, Nausea, Increased Appetite, Fatigue, Akathisia and Hyperkinesia, Dystonia, Oculogyration, Muscle Rigidity, Parkinsonism, Tremor, Extrapyramidal Disorder, Constipation, Dry Mouth, Salivary Hypersecretion, Stomach Discomfort, Vomiting, Fatigue, Irritability, Increased Weight, Increased Appetite, Bradykinesia, Blepharospasm, Torticollis, Gait Disturbance, Masked Facies, Tremor, Insomnia, Hypertension, Dyspepsia, Toothache, Arthralgia, Pain in Extremity, Headache, Depression, Anxiety, Anger, Dysmenorrhea, Oropharyngeal Pain, Nasal Congestion, Dyspnea, Rash, Edema Peripheral, Increased Weight, Suicidal Ideation, Dystonia, Parkinsonism, Oculogyration, Choking, Oropharyngeal Muscular Dysfunction, Hypoesthesia, Anemia, Thrombocytopenia, Temporary Bundle Branch Block, Accommodation Disorder, Swollen Tongue, Idiosyncratic Drug Reaction, Hyponatremia, Dysarthria, Diplopia, Blurred Vision, Gastroesophageal Reflux Disease, Fall, Photosensitivity Reaction, Enuresis, death"
202,SAPHRIS,boxed warnings,"Increased mortality, Death"
203,SAPHRIS,warnings and precautions,"Cerebrovascular Adverse Events, Stroke, Transient Ischemic Attack, Neuroleptic Malignant Syndrome, Tardive Dyskinesia, Metabolic Changes, Hyperglycemia, Dyslipidemia, Weight Gain, Hypersensitivity Reactions, Anaphylaxis, Angioedema, Orthostatic Hypotension, Syncope, Dizziness, Tachycardia, Bradycardia, Leukopenia, Neutropenia, Agranulocytosis, QT Prolongation, Seizures, Potential for Cognitive and Motor Impairment, Suicide, Death, Dysphagia, Aspiration, Hyperprolactinemia."
204,DUREZOL,adverse reactions,"elevated intraocular pressure, optic nerve damage, visual acuity defects, field defects, posterior subcapsular cataract formation, secondary ocular infection, herpes simplex infection, perforation of the globe, corneal edema, ciliary hyperemia, conjunctival hyperemia, eye pain, photophobia, posterior capsule opacification, anterior chamber cells, anterior chamber flare, conjunctival edema, blepharitis, reduced visual acuity, punctate keratitis, eye inflammation, iritis, application site discomfort, application site irritation, corneal pigmentation, corneal striae, episcleritis, eye pruritis, eyelid irritation, eyelid crusting, foreign body sensation, increased lacrimation, macular edema, sclera hyperemia, uveitis, blurred vision, headache, increased IOP, limbal hyperemia, conjunctival hyperemia, dry eye, iridocyclitis, death."
205,DUREZOL,warnings and precautions,"Intraocular pressure increase, glaucoma, damage to the optic nerve, defects in visual acuity and fields of vision, Cataracts, posterior subcapsular cataract formation, Delayed healing, bleb formation, perforations in the cornea or sclera, Bacterial infections, secondary ocular infections, Viral infections, exacerbation of viral infections of the eye, Fungal infections, fungal invasion, persistent corneal ulceration, Death."
206,ZYDELIG,adverse reactions,"Hepatotoxicity, liver toxicity, Severe Diarrhea, severe colitis, Pneumonitis, Intestinal Perforation, Severe Cutaneous Reactions, severe skin reactions, Anaphylaxis, Neutropenia, decreased neutrophil count, Diarrhea, nausea, cough, pneumonia, abdominal pain, chills, rash, vomiting, gastroesophageal reflux disease, stomatitis, headache, pyrexia, pain, nasal congestion, sepsis, bronchitis, sinusitis, urinary tract infection, arthralgia, night sweats, dyspnea, decreased appetite, insomnia, ALT increased, AST increased, GGT increased, hypertriglyceridemia, hyperglycemia, hypoglycemia, hyponatremia, Fatigue, asthenia, peripheral edema, upper respiratory tract infection, death"
207,ZYDELIG,boxed warnings,"Hepatic toxicity, Severe diarrhea, Colitis, Pneumonitis, Intestinal perforation, Death"
208,ZYDELIG,warnings and precautions,"Severe cutaneous reactions, toxic epidermal necrolysis, dermatitis exfoliative, rash, rash erythematous, rash generalized, rash macular, rash maculo-papular, rash papular, rash pruritic, exfoliative rash, skin disorder, anaphylaxis, neutropenia, hepatotoxicity, severe diarrhea, colitis, pneumonitis, intestinal perforation, death."
209,KALBITOR,adverse reactions,"Hypersensitivity reactions, anaphylaxis, headache, nausea, diarrhea, pyrexia, injection site reactions, nasopharyngitis, fatigue, upper respiratory tract infection, vomiting, pruritus, upper abdominal pain, death"
210,KALBITOR,boxed warnings,"Anaphylaxis, Hypersensitivity reactions"
211,KALBITOR,warnings and precautions,"Anaphylaxis, death, chest discomfort, flushing, pharyngeal edema, pruritus, rhinorrhea, sneezing, nasal congestion, throat irritation, urticaria, wheezing, hypotension, rash."
212,ADCETRIS,adverse reactions,"Peripheral Neuropathy, Anaphylaxis, Infusion Reactions, Hematologic Toxicities, Serious Infections, Opportunistic Infections, Tumor Lysis Syndrome, Increased Toxicity in the Presence of Severe Renal Impairment, Increased Toxicity in the Presence of Moderate or Severe Hepatic Impairment, Hepatotoxicity, Progressive Multifocal Leukoencephalopathy, Pulmonary Toxicity, Serious Dermatologic Reactions, Death"
213,ADCETRIS,boxed warnings,"Progressive multifocal leukoencephalopathy (PML), JC virus infection, Death"
214,ADCETRIS,warnings and precautions,"Peripheral neuropathy, neuropathy, sensory neuropathy, motor neuropathy, hypoesthesia, hyperesthesia, paresthesia, discomfort, burning sensation, neuropathic pain, weakness, anaphylaxis, infusion reactions, hematologic toxicities, severe neutropenia, thrombocytopenia, anemia, febrile neutropenia, serious infections, opportunistic infections, pneumonia, bacteremia, sepsis, septic shock, tumor lysis syndrome, increased toxicity, severe renal impairment, moderate hepatic impairment, severe hepatic impairment, hepatotoxicity, hepatocellular injury, transaminases elevation, bilirubin elevation, progressive multifocal leukoencephalopathy, JC virus infection, PML, pulmonary toxicity, pneumonitis, interstitial lung disease, acute respiratory distress syndrome, dermatologic reactions, Stevens-Johnson syndrome, toxic epidermal necrolysis, embryo-fetal toxicity, fetal harm, decreased embryo viability, fetal malformations, death."
215,BESIVANCE,adverse reactions,"conjunctival redness, blurred vision, eye pain, eye irritation, eye pruritus, headache"
216,BESIVANCE,warnings and precautions,"Growth of Resistant Organisms, Overgrowth of non-susceptible organisms, Fungal overgrowth, Super-infection, Signs or symptoms of bacterial conjunctivitis, death."
217,CLEVIPREX,adverse reactions,"hypotension, reflex tachycardia, headache, nausea, vomiting, death, acute renal failure, atrial fibrillation, myocardial infarction, cardiac arrest, syncope, dyspnea, increased blood triglycerides, ileus, hypersensitivity, decreased oxygen saturation"
218,CLEVIPREX,warnings and precautions,"Hypotension, Reflex tachycardia, Negative inotropic effects, Exacerbate heart failure, Rebound hypertension, Death"
219,XTANDI,adverse reactions,"Seizure, asthenia/fatigue, back pain, decreased appetite, constipation, arthralgia, diarrhea, hot flush, upper respiratory tract infection, peripheral edema, dyspnea, musculoskeletal pain, weight decreased, headache, hypertension, dizziness/vertigo, spinal cord compression, cauda equina syndrome, paresthesia, mental impairment disorders, hypoesthesia, insomnia, anxiety, hematuria, pollakiuria, fall, non-pathologic fractures, pruritus, dry skin, epistaxis, dysgeusia, restless legs syndrome, gynecomastia, dyspnea, exertional dyspnea, dyspnea at rest."
220,XTANDI,warnings and precautions,"Seizure, death"
221,BOSULIF,adverse reactions,"Gastrointestinal toxicity, Myelosuppression, Hepatic toxicity, Fluid retention, Renal toxicity, diarrhea, nausea, thrombocytopenia, vomiting, abdominal pain, rash, anemia, pyrexia, fatigue, anaphylactic shock, increased alanine aminotransferase, headache, cough, increased aspartate aminotransferase, neutropenia, edema, arthralgia, decreased appetite, respiratory tract infection, nasopharyngitis, back pain, asthenia, pruritus, dizziness, dyspnea, death, febrile neutropenia, pericardial effusion, pericarditis, tinnitus, gastritis, acute pancreatitis, gastrointestinal hemorrhage, chest pain, pain, hepatotoxicity, toxic hepatitis, cytolytic hepatitis, abnormal hepatic function, liver disorder, liver injury, drug hypersensitivity, anaphylactic shock, pneumonia, influenza, bronchitis, electrocardiogram QT prolonged, increased blood creatine phosphokinase, increased blood creatinine, hyperkalemia, dehydration, myalgia, dysgeusia, acute renal failure, renal failure, pleural effusion, acute pulmonary edema, respiratory failure, pulmonary hypertension, urticaria, pruritus, acne, erythema multiforme, exfoliative rash, drug eruption"
222,BOSULIF,warnings and precautions,"Diarrhea, nausea, vomiting, abdominal pain, thrombocytopenia, anemia, neutropenia, ALT elevation, AST elevation, transaminase elevations, pericardial effusion, pleural effusion, pulmonary edema, peripheral edema, decline in estimated glomerular filtration rate (eGFR), fetal harm"
223,CARBAGLU,adverse reactions,"Infections, vomiting, abdominal pain, pyrexia, tonsillitis, anemia, ear infection, diarrhea, nasopharyngitis, headache, dysgeusia, asthenia, hyperhidrosis, influenza, pneumonia, hemoglobin decreased, weight decreased, anorexia, somnolence, rash."
224,CARBAGLU,warnings and precautions,"Hyperammonemia, Injury to the brain, Death"
225,SIMPONI,adverse reactions,"Serious Infections, Malignancies, death, Infections, sepsis, pneumonia, cellulitis, abscess, opportunistic infections, tuberculosis, invasive fungal infections, malignancy, liver enzyme elevations, severe hepatic reactions, acute liver failure, autoimmune disorders, autoantibodies, lupus-like syndrome, infusion reactions, rash, immunogenicity, antibodies, golimumab-treated patients, neutralizing antibodies, other adverse reactions, upper respiratory tract infection, viral infection, bronchitis, hypertension, rash, pyrexia, leukopenia, superficial fungal infection, sinusitis, lower respiratory tract infection, pyelonephritis, alanine aminotransferase increased, aspartate aminotransferase increased, neutrophil count decreased, dizziness, paresthesia, constipation, neoplasm benign and malignant, melanoma, serious systemic hypersensitivity reactions, anaphylactic reaction, sarcoidosis, interstitial lung disease, skin exfoliation, bullous skin reactions."
226,SIMPONI,boxed warnings,"Serious infections, Hospitalization, Death, Tuberculosis (TB), Bacterial sepsis, Invasive fungal infections, Histoplasmosis, Opportunistic infections, Lymphoma, Malignancies"
227,SIMPONI,warnings and precautions,"Serious infections, death, invasive fungal infections, hepatitis B reactivation, malignancies, lymphoma, heart failure, demyelinating disease, exacerbation, new onset, hypersensitivity reactions, anaphylaxis"
228,BENLYSTA,adverse reactions,"Mortality, death, serious infections, malignancy, hypersensitivity reactions, anaphylaxis, infusion reactions, depression, nausea, diarrhea, pyrexia, nasopharyngitis, bronchitis, insomnia, pain in extremity, migraine, pharyngitis, cystitis, leukopenia, gastroenteritis viral, fatal anaphylaxis"
229,BENLYSTA,warnings and precautions,"Mortality, death, Serious Infections, fatal infections, Progressive Multifocal Leukoencephalopathy (PML), neurological deficits, fatal cases, Hypersensitivity Reactions, Anaphylaxis, acute hypersensitivity reactions, non-acute hypersensitivity reactions, serious reactions, death, Depression, suicidality, serious depression, suicidal behavior, suicides, Infusion Reactions, serious infusion reactions, Malignancy"
230,TOVIAZ,adverse reactions,"dry mouth, constipation, angina, chest pain, gastroenteritis, QT prolongation on ECG, dyspepsia, nausea, abdominal pain upper, urinary tract infection, upper respiratory tract infection, dry eyes, dysuria, urinary retention, cough, dry throat, edema peripheral, back pain, insomnia, ALT increased, GGT increased, rash, urinary retention, diverticulitis, irritable bowel syndrome, electrocardiogram QT corrected interval prolongation, blurred vision, palpitations, hypersensitivity reactions, angioedema with airway obstruction, face edema, dizziness, headache, somnolence, urticaria, pruritus"
231,TOVIAZ,warnings and precautions,"Angioedema, face angioedema, lips angioedema, tongue angioedema, larynx angioedema, urinary retention, gastrointestinal motility, constipation, narrow-angle glaucoma, somnolence, central nervous system effects, headache, dizziness, myasthenia gravis"
232,ENTEREG,adverse reactions,dyspepsia
233,ENTEREG,boxed warnings,"Myocardial infarction, Heart attack, Death"
234,ENTEREG,warnings and precautions,"Myocardial infarctions, death, abdominal pain, nausea, vomiting, diarrhea, severe hepatic impairment, end-stage renal disease, complete gastrointestinal obstruction, surgery, pancreatic anastomosis, gastric anastomosis"
235,VIZAMYL,adverse reactions,"flushing, headache, increased blood pressure, nausea, dizziness"
236,VIZAMYL,warnings and precautions,"Hypersensitivity reactions, flushing, dyspnea, Image interpretation errors, false positives, Radiation risk"
237,AMPYRA,adverse reactions,"Seizures, Anaphylaxis, Urinary Tract Infections, Death, Insomnia, Dizziness, Headache, Nausea, Asthenia, Back pain, Balance disorder, Multiple sclerosis relapse, Paresthesia, Nasopharyngitis, Constipation, Dyspepsia, Pharyngolaryngeal pain"
238,AMPYRA,warnings and precautions,"Seizures, death, anaphylaxis, renal impairment, urinary tract infections"
